Apparatus and method for removing material from body of patient
By adopting progressive cavity pump and mechanical engagement technology in interventional radiology equipment, the blood loss and equipment complexity problems during thrombectomy during thrombectomy are solved, and efficient removal of soft and hard clots and vascular damage are achieved. The reduction.
Patent Information
- Application Number
- CN202380024709.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-10-11
- Filing Date
- 2023-03-02
- Publication Date
- 2024-11-12
Smart Images

Figure CN118946722A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of each of U.S. Provisional Patent Application No. 63 / 315,764, entitled “DEVICES AND METHODS FOR ADMINISTERING AND REMOVING MATERIAL FROM A PATIENT,” filed on March 2, 2022, U.S. Provisional Patent Application No. 63 / 359,990, entitled “DEVICES AND METHODS FOR REMOVING UNWANTED MATERIAL FROM A PATIENT,” filed on July 11, 2022, and U.S. Provisional Patent Application No. 63 / 415,201, entitled “DEVICES AND METHODS FOR REMOVING UNWANTED MATERIAL FROM A PATIENT,” filed on October 11, 2022. The entire contents of the foregoing applications are incorporated herein by reference for all purposes. Technical Field
[0003] The present disclosure relates generally to the field of medicine, and more particularly to the field of interventional radiology.Described herein are apparatus and methods for removing unwanted material from a patient's body. Background Art
[0004] Removing material from a patient's body is an important part of routine and emergency medical care. For example, in the field of interventional radiology, removing clots (including thrombi or thromboemboli) from blood vessels or artificial vascular grafts is called thrombectomy, and a variety of devices have been proposed to meet this demand. The limitations of some existing devices include, but are not limited to, heavy blood loss during clot extraction, difficulty in removing a variety of clot compositions including both soft clots and hard clots, difficulty in removing clots that adhere to the vessel wall, damage to the vessel during clot extraction, large device size, clot fragmentation during removal and subsequent embolism, and the amount of capital equipment required to operate the device. It would be advantageous to be able to remove material (e.g., clots, stones, malignant tissue) from a body lumen or cavity and overcome some or all of these limitations. Summary of the invention
[0005] The present invention relates to an apparatus and method for removing material from a patient's body. In one application, the apparatus and method are used to remove a clot during a thrombectomy procedure. The apparatus may include a tissue engaging portion, a pumping assembly, a catheter body, a handle assembly, and a collection assembly. When the apparatus is activated, the clot is engaged by the tissue engaging portion, drawn into the pumping assembly, and then gradually pumped into the catheter body, through the handle assembly, and into the collection assembly, thereby removing the clot from the blood vessel.
[0006] In one embodiment, the pumping assembly includes a rotor and a stator, which form a cavity or a recess, and when the rotor rotates, the cavity or the recess transfers the material through the cavity or the recess and enters the catheter body. In one embodiment, the pumping assembly is a progressive cavity pump. In one example, the rotor extends into the tissue engaging portion at the distal end of the device. When activated, the tissue engaging portion produces mechanical and / or vacuum-assisted engagement of clots and materials (e.g., blood and clots) so that they are taken from the distal end of the tissue engaging portion and enter the pumping assembly, which is configured to generate enough pressure to move the material into the catheter body, through the handle assembly and into the collection assembly. The tissue engaging portion can also help to minimize clot fragmentation and subsequent embolism. By engaging clots, optimizing the size of the cavity and controlling the rotation speed of the rotor, blood loss can also be minimized.
[0007] In some cases, the pumping assembly can also be configured to be positioned at a predetermined or adjustable angle to the axis of the catheter body. In this case, the catheter body can be rotated via the handle assembly to better engage a clot in a larger vessel or adhered to the vessel wall. This can also allow for the use of a smaller device.
[0008] In some embodiments, a pumping assembly may be slidably positioned within an engaging conduit to aid in the uptake of material into the conduit.
[0009] The foregoing is an overview and may be limited in detail. The above-mentioned aspects and other aspects, features and advantages of the present technology are described below in conjunction with various embodiments, with reference to the specification, claims and drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] Figure 1A An embodiment of a device according to the present disclosure is illustrated in an isometric view.
[0011] Figure 1B Picture shows Figure 1A Exploded parts view of the device.
[0012] Figure 2A A detailed view of the distal end is shown. Figure 1A equipment.
[0013] Figure 2B Exploded view of the components Figure 1A equipment.
[0014] Figure 2C Shown is a front view of the pumping assembly with dimensions.
[0015] Figure 2D A side view of the pumping assembly with dimensions is shown.
[0016] Figure 2E Representative flow equations for pumping components are illustrated.
[0017] Figure 3A The diagram shows the Figure 1A The device wherein the stator and the distal sleeve are transparent.
[0018] Figure 3B Picture shows Figure 1A An apparatus wherein a rotor partially rotates and a first cavity begins to form.
[0019] Figure 3C The diagram shows a further rotation of the rotor Figure 1A equipment.
[0020] Figure 3D Picture shows Figure 1A The device wherein the rotor rotates further and a second cavity begins to form.
[0021] Figure 3E The diagram shows a further rotation of the rotor Figure 1A equipment.
[0022] Figure 3F Picture shows Figure 1A The device wherein the rotor rotates further and a third cavity begins to form.
[0023] Figure 4 Exploded view of the components Figure 1A An embodiment of a handle assembly of a device.
[0024] Figure 5 Picture shows Figure 4 A cross-sectional view of the handle assembly.
[0025] Fig. 6A Illustration of a clot approaching a blood vessel Figure 1A equipment.
[0026] Figure 6B Illustration of clot ingestion Figure 1A equipment.
[0027] Figure 6C Diagram showing further uptake of clot Figure 1A equipment.
[0028] Fig.6D Diagram showing further uptake of clot Figure 1A equipment.
[0029] Fig. 6E The image shows a clot that has been ingested. Figure 1A equipment.
[0030] Figure 7 An embodiment of an apparatus according to the present disclosure for removing a clot from an iliac vein is illustrated.
[0031] Figure 8 Illustration of the use Figure 1A Embodiments of the method of the device.
[0032] Fig. 9A A pumping assembly that may be incorporated into embodiments of the present disclosure is illustrated.
[0033] Fig. 9B Alternative pumping assemblies are illustrated that may be incorporated into embodiments of the present disclosure.
[0034] Fig. 10A Another alternative pumping assembly that may be incorporated into embodiments of the present disclosure is illustrated.
[0035] Fig. 10B Picture shows Fig. 10A An exploded component view of the embodiment shown in FIG.
[0036] Fig.11A The initial configuration is shown in cross section. Fig. 10A equipment.
[0037] Fig. 11B The diagram shows a rotor partially rotating Fig. 10A equipment.
[0038] Fig. 11C The diagram shows a further rotation of the rotor Fig. 10A equipment.
[0039] Fig. 12A An embodiment of a device having an aspiration channel and an infusion channel is illustrated.
[0040] Fig. 12B Picture shows Fig. 12A An exploded component view of the embodiment shown in FIG.
[0041] Fig.13A An embodiment of an apparatus having a stator with uniform wall thickness is illustrated.
[0042] Fig. 13B Picture shows Fig.13AAn exploded component view of the embodiment shown in FIG.
[0043] Fig.14A An embodiment of a tissue engaging portion of a device according to the present disclosure and including an extension feature is illustrated.
[0044] Fig. 14B An alternative tissue engaging portion embodiment comprising a stator funnel is illustrated.
[0045] Fig. 14C Yet another tissue engaging portion embodiment comprising a trochanter extension tip is illustrated.
[0046] Fig.14D Another tissue engaging portion embodiment comprising an extension line is illustrated.
[0047] Fig.14E Another tissue engaging portion embodiment comprising a capped end is illustrated.
[0048] Fig.14F Another tissue engaging portion embodiment comprising a standoff is illustrated.
[0049] Figure 14G Another embodiment of a tissue engaging portion comprising an infusion outlet is illustrated.
[0050] Fig.14H Another embodiment of a tissue engaging portion comprising an infusion outlet is illustrated.
[0051] Fig.15A An embodiment of a device according to the present disclosure comprising a guidewire access hole is illustrated.
[0052] Fig. 15B Picture shows Fig.15A Cross-sectional view of the device.
[0053] Fig. 15C A side view of a device having multiple distal bends is illustrated.
[0054] Fig.16A A front view of a device according to the present disclosure including a visualization component is illustrated.
[0055] Fig. 16B Picture shows Fig.16A Isometric view of the equipment in the.
[0056] Fig. 16C Picture shows Fig. 16B Exploded view of the device in .
[0057] Fig.17A A front view of a device according to the present disclosure comprising two visualization components is illustrated.
[0058] Fig. 17B Picture shows Fig.17A Isometric view of the equipment in the.
[0059] Fig. 17C Picture shows Fig. 17B Exploded view of the device in .
[0060] Fig.18A An aspiration catheter approaching a clot within a blood vessel is illustrated.
[0061] Fig.18B Illustration of the joint Fig.18A clot aspiration catheter.
[0062] Fig. 18C The diagram shows Fig.18A A clot engaging device according to the present disclosure.
[0063] Fig.18D Illustration of removal Fig.18A of clot Fig. 18C equipment.
[0064] Fig.18E The image shows the removal Fig.18A of clots.
[0065] Fig.19A An embodiment of an apparatus according to the present disclosure comprising a filter is illustrated.
[0066] Fig.19B Picture shows Fig.19A A device in which the filter is shown in an exploded view.
[0067] Fig.19C Another embodiment of an apparatus according to the present disclosure comprising a series of filters is illustrated.
[0068] Fig. 20 An embodiment of an apparatus according to the present disclosure having a conduit filter is illustrated.
[0069] Fig.21 An embodiment of a device according to the present disclosure having an expandable funnel is illustrated.
[0070] Fig. 22 An embodiment of a device according to the present disclosure having a pumping assembly in a handle is illustrated. DETAILED DESCRIPTION
[0071] Conventional and known removal devices include a variety of mechanisms and methods for removing unwanted materials from a patient's body. Some devices include a suction catheter that uses a vacuum pump connected to a catheter to aspirate materials such as thrombi from a blood vessel like a straw. The suction catheter may be challenged by thicker materials (such as subacute or chronic clots) that are not easily compressed into the catheter lumen and may therefore block such a device. In addition, the suction catheter may adversely produce significant suction flow and therefore remove a large amount of blood from the patient's body. Doing so increases the risk of exsanguination and the possibility of needing a blood transfusion, as well as other risks.
[0072] Certain conventional removal devices have been described that use expandable metal frames and baskets to mechanically grasp unwanted material, such as a clot, in order to pull the material out of the blood vessel. These devices can sometimes cause vascular damage to the intimal wall, venous valves, or other tissue structures, particularly as they are removed from the patient. Additionally, these devices can sometimes allow fragments of the unwanted material to embolize and travel further downstream in the blood vessel, thereby increasing the risk of other problems such as pulmonary embolism or stroke.
[0073] Still other conventional devices use spinning elements to shred unwanted material, which can include thrombi and wall-adherent plaque. Devices with spinning elements can cause significant damage to vascular structures, while also being prone to clogging, especially compared to other material removal devices and methods. These devices also often require large capital equipment to control them, and may require a separate suction source to remove the material once it has been shredded.
[0074] Devices and methods are described herein that overcome the challenges previously described, etc., while providing substantial additional benefits associated with removing unwanted materials from a patient. During use, the disclosed device is typically inserted into a patient's physiological lumen or cavity near the material to be removed from the patient. In one aspect of the disclosed device, the device includes a pump for generating suction so that there is a low dead volume between the pump and the unwanted material to be removed. In some embodiments, the pump is a positive displacement pump that is located within the lumen of the catheter and can even be located at the distal end of the catheter so that the dead volume or the volume of fluid between the pump and the in-situ unwanted material is minimized and may even be negligible. By reducing the amount of dead space, the pump can provide a greater vacuum to the unwanted material due to minimal head loss through the conduit. The pump can then discharge the unwanted material from the patient through the lumen of the catheter. In addition, the benefit of positive displacement pumps is that they do not require a large flow rate to generate a high level of vacuum, and therefore can minimize the blood loss associated with traditional suction catheters.
[0075] Positive displacement pumps move fluids by repeatedly closing a fixed volume and mechanically moving it through a system in a cyclic motion. Examples of positive displacement pumps include piston pumps, diaphragm pumps, gear pumps, cam pumps, vane pumps, and progressive cavity pumps. Although each of these pump types can be used for material removal and within the scope of the present disclosure, progressive cavity pumps (also referred to as Moineau pumps, eccentric screw pumps, or screw pumps) are particularly well suited for removing unwanted materials from a patient's body. Progressive cavity pumps include a stator and a self-spinning spiral rotor with a slotted spiral lumen. The stator and rotor are designed so that one or more cavities are formed between the spiral rotor and the stator spiral lumen when they are joined. As discussed in further detail below, the cavity can be a contained fluid volume that can be completely sealed (e.g., due to the interference fit between the rotor and the stator, which can be promoted by a stator formed of an elastomeric material). Alternatively, the present disclosure contemplates that the stator and rotor can be dimensioned so that the two components are not sealed. Among other advantages, such a "leaky" configuration can reduce the volume of certain fluids (e.g., blood) transferred by a progressive cavity pump while still facilitating the aspiration of solid / semi-solid materials and more viscous fluids. In the case of blood, the result can be reduced blood loss and a lower risk of a patient needing a transfusion.
[0076] In certain embodiments of the present disclosure, the pitch of the helical rotor is about half of the pitch of the stator helical lumen. Spinning the rotor causes one or more cavities to move along the axis of the pump, depending on the direction of the rotor spin. Progressive cavity pumps are unique in that they are combined with spiral elements, such as Archimedes screw pumps, also known as water screw pumps, compared to other pumps. The typical design of an Archimedes screw pump includes a cylindrical screw that spins in a cylindrical or tubular lumen. Such a pump does not include or form a closed cavity between its stator and rotor, and generally utilizes a pressure difference generated by the rotation speed of the screw to draw the fluid into the pump. Some Archimedes screw designs can work well enough for pumping viscous fluids such as blood, but may be challenged by more viscous materials such as thrombi. In contrast, a progressive cavity pump forms a series of closed cavities that can be completely or partially sealed. During operation, the progressive cavity pump moves a discrete volume for each rotation of the rotor. As a result, the output of the progressive cavity pump is proportional to the number of rotations of the rotor and is independent of the rotational speed (as is the case with pressure-based pumps such as conventional screw pumps). Therefore, the progressive cavity pump has applications where the amount of material being pumped needs to be well controlled, such as dosing applications. The controlled flow provided by the progressive cavity pump is also advantageous in the case of material removal because it overcomes some challenges associated with existing thrombectomy devices, in which excessive blood loss is difficult to control. In addition, as briefly noted above, the progressive cavity pump is also very suitable for applications in which the pumped material is viscous or includes a slurry of solid material, such as a thrombectomy procedure, and can overcome some limitations of existing thrombectomy equipment being blocked by more viscous materials. However, progressive cavity pumps are often too large, too expensive and too complex to be feasible for use in catheters. For example, conventional progressive cavity pumps are typically used in large-scale applications such as pumping of sewage or oil. In such applications, the progressive cavity pump has considerable mechanical complexity due to the need for various bearings and universal joints.
[0077] In certain embodiments, the progressive cavity pump may also include elements to improve material removal. For example, the distal end of the pumping assembly may include a tissue engaging portion configured to ingest elastic and viscous materials into the pumping assembly by mechanically grasping or pinching the material and applying a suction force.
[0078] exist Figure 1A , a device 102 for removing material from a patient's body (e.g., from a blood vessel) is shown. The device 102 includes a tissue engaging portion 108, a pumping assembly 110, a catheter body 104, a handle assembly 106, and a collection assembly 112. The tissue engaging portion 108 is configured to engage the material via mechanical interaction with the material and / or via the generation of a suction flow or vacuum pressure that draws the material into the tissue engaging portion 108.
[0079] Figure 1B Additional details of the device 102 are depicted. In the illustrated embodiment, the pumping assembly 110 includes a stator 114, a rotor 116, a distal sleeve 120, and a positioning element 118. The stator 114 is assembled within the distal sleeve 120, which is connected to the catheter body 104 and the positioning element 118. The rotor 116 is attached to the torque member 122 and rotates therewith. The handle assembly 106 includes a catheter hub 124 for rotating the catheter body 104, a housing composed of two shells 126, a drive system 130 for enabling the torque member 122 to rotate, and a manifold 128 for sealing the drive system 130 with the removed material and for directing the removed material to the collection assembly 112 through the outlet tube 132. The handle assembly 106 also includes a cable 134 and a controller 136.
[0080] In one embodiment, the pumping assembly 110 is a progressive cavity pump in which a series of cavities are formed between the rotor 116 and the stator 114 that move proximally when the rotor 116 spins in one direction and move distally when the rotor 116 spins in the opposite direction. Progressive cavity pumps are known by other names, such as eccentric screw pumps, screw pumps, or Moineau pumps. Progressive cavity pumps are well suited for applications requiring fluid metering, pumping viscous or shear sensitive materials, and pumping slurries containing abrasive solids.
[0081] exist Figure 2A , a detailed view of the distal end of the device 102 is shown, and further illustrates the tissue engaging portion 108 and the pumping assembly 110. Generally speaking, the tissue engaging portion 108 includes elements that mechanically engage tissue to facilitate subsequent uptake of the tissue by the device 102. In some embodiments, the tissue engaging portion 108 includes a rotor distal tip 212 (at the distal tip of the rotor 116) of the rotor 116. Figure 2B ), the stator distal segment 202 of the stator 114, the slot 220 defined by the stator 114, and a portion of the distal sleeve 120.
[0082] In the illustrated embodiment, the stator distal segment 202 extends from the distal sleeve 120 and is oriented using a stator alignment feature 204. The stator alignment feature 204 provides a rotational orientation between the stator 114 and the distal sleeve 120. The slot 220 allows the rotor distal tip 212 of the rotor 116 to move therein and create an open cavity 222 at the distal end of the device 102. As the rotor 116 rotates, the rotor distal tip 212 spins and translates across the slot 220. This action mechanically engages the material (e.g., by pinching or trapping the material between the rotor distal tip 212 and the wall defining the slot 220). The pumping assembly 110 can also generate a suction flow and / or vacuum pressure to pull tissue / material into the open cavity 222. By doing so, the device 102 ingests material into the pumping assembly 110 for subsequent removal from the patient.
[0083] In some embodiments, the distal sleeve 120 may include a distal bend 206 that orients the distal sleeve 120 at an angle relative to the catheter body 104. The distal bend 206 can enhance the ability of the tissue engaging portion 108 to engage materials (e.g., clots) that adhere to the vessel wall and / or increase the reach of the device 102, for example, to handle larger vessels without requiring larger diameter devices. In some embodiments, the distal bend 206 can be adjustable or formable. For example, the catheter body 104 can include one or more steering features (e.g., pull cables) that can be used to steer and lock the distal bend 206.
[0084] As previously noted, the stator 114 includes a slot 220 (which may be oblong in shape) at its distal side. The slot 220 continues to spirally pass through the stator 114 to form a stator spiral lumen 210. In certain embodiments, the stator 114 may be formed of an elastic material, such as silicone, polyurethane, or any other suitable material that can be molded or otherwise formed to include the stator spiral lumen 210. Among other things, the use of an elastic material facilitates the sealing of the stator 114 against the rotor 116. In certain non-limiting examples, the stator 114 material may have a durometer hardness of from about Shore 20A and including about Shore 20A to about Shore 100D and including about Shore 100D, or from about Shore 20A and including about Shore 20A to about Shore 60D and including about Shore 60D, or about Shore 80A. In other embodiments, the stator may be constructed of a more rigid material such as plastic, stainless steel, or any other suitable material.
[0085] The rotor 116 generally has a rotor helical section 214 having a geometry similar to that of the stator helical lumen 210, albeit with a reduced pitch. For example, in certain embodiments, the pitch of the rotor helical section 214 can have approximately half the helical pitch of the stator helical lumen 210 (or, in other words, the stator helical lumen 210 can have approximately twice the pitch of the rotor helical section 214). Alternative geometries of the stator helical lumen 210 and the rotor helical section 214 can be configured to have similar functionality and will be discussed further later in this disclosure.
[0086] The rotor 116 can be formed of a variety of materials, including but not limited to nylon, polycarbonate, stainless steel, nitinol, or any other suitable material (e.g., other plastics or metals). In some embodiments, the rotor 116 can be formed of a plastic material and can be formed using one or more of injection molding, 3D printing, extrusion, or similar manufacturing methods. However, in general, the rotor 116 can be formed of a harder or more rigid material than the material of the stator 114. Among other things, selecting a harder / more rigid material for the rotor 116 and a more flexible / compliant material for the stator 114 facilitates sealing between the rotor 116 and the stator 114 during operation.
[0087] The geometry of the stator 114 and the rotor 116 generally forms a helical path of contact or near contact. During operation, at least one closed cavity 224 is formed in the space between the rotor helical segment 214 and the stator helical lumen 210. More specifically, as the rotor 116 rotates within the stator 114, the cavity is formed between the rotor 116 and the stator 114 and travels proximally toward the catheter body 104 as the rotor 116 rotates. For example, Figure 2D Each of the open cavity 222 and the closed cavity 224 is illustrated. During operation, material is initially captured in the open cavity 222. As the rotor 116 rotates further, the open cavity 222 moves proximally and eventually closes, forming a closed cavity, such as the closed cavity 224. As the rotor 116 rotates further relative to the stator 114, the closed cavity 224 eventually advances to the proximal end of the stator spiral lumen 210 and opens, releasing the captured material into the catheter body 104. In this way, the material drawn into the pumping assembly 110 is captured in the closed cavity 224 and is subsequently moved into the catheter body 104 to be removed from the patient. Among other advantages, this method allows the removal of material (e.g., clots) without removing excess fluid (e.g., blood).
[0088] In one embodiment, the closed cavity 224 is fluid-tight. For example, the seal can be achieved by the contact between the stator 114 and the rotor 116, and in some embodiments where the stator 114 and the rotor 116 have an interference fit, by the additional compression of the stator 114 by the rotor 116. For example, the compression of the stator 114 by the rotor 116 can be from about 0% and including about 0% to about 40% and including about 40%, or from about 2% and including about 2% to about 10% and including about 10%, or about 5%. The compression does not have to be the same along the entire length of the contact between the stator 114 and the rotor 116.
[0089] In other embodiments, the closed cavity formed between the stator 114 and the rotor 116 may not be fluid-tight, that is, there may be a spacing gap between the rotor 116 and the stator 114. Even without a completely sealed cavity, the pumping assembly 110 can still work similarly to the case of a sealed cavity, particularly for removing solid materials. In some embodiments, the spacing gap can beneficially reduce the friction between the stator 114 and the rotor 116 due to the lack of contact or elastic interference between the two components. The spacing gap can also allow for greater tolerance variations of the rotor 116 and the stator 114, and can enable both components to be made of rigid materials. Including a spacing gap can also reduce the flow rate through the pumping assembly 110, for example, by allowing fluid to leak distally from the pumping assembly 110. Among other advantages, such leakage can result in the removal of solid or semi-solid materials from the patient without removing a significant amount of blood or other fluids. For example, the ratio of blood removed to clot removed can be from about 1:10 and including to about 50:1 and including, or from about 1:1 and including to about 20:1 and including, or about 10: 1. For purposes of this disclosure, and unless otherwise indicated, cavities described in this disclosure as "closed" should be considered to encompass both fluid-tight and unsealed cavities.
[0090] The illustrated pumping assembly 110 includes a distal sleeve 120 for containing the stator 114 and can provide support so that the stator 114 can be compressed between the rotor 116 and the distal sleeve 120 to allow a closed cavity, such as the closed cavity 224, to be formed. The stator 114 generally includes a stator body segment 208 that is sized to fit within the distal sleeve 120. The distal sleeve 120 can be an integral part of the catheter body 104, or can be a separate part attached to the catheter body 104, such as Figure 2B The distal sleeve 120 is connected to the catheter body 104 so that the stator distal section 202 maintains a tubular profile.
[0091] Certain embodiments include a distal bend 206 in the distal sleeve 120 that generally angles the tip of the device away from the axis of the catheter body 104. The angle of the distal bend 106 can be from about 0° and including about 0° to about 75° and including, or from about 10° and including about 10° to about 45° and including, or about 20°.
[0092] In certain embodiments, the distal sleeve 120 can be a laser cut stainless steel or nitinol tube, a plastic tube, an injection molded component, a machined component, or have any other suitable configuration.
[0093] In some embodiments, the pumping assembly 110 may include a positioning element 118 that resides inside the distal sleeve 120 and engages with the stator 114 and the rotor hub 216 so that the axial position of the rotor 116 is maintained relative to the stator 114. The positioning element may include a distal hard stop, a proximal hard stop, or other alignment features that axially and rotationally position the rotor 116 or the stator 114. Among other things, the positioning element 118 ensures that the distal end of the rotor 116 is in the correct axial position and does not extend beyond the distal end of the stator distal segment 202 in some embodiments, otherwise it may cause vascular damage. The positioning element 118 can further engage with an internal feature (e.g., a shoulder, a slot, a protrusion, a key, a keyway, etc.) within the distal sleeve 120 so that the position and orientation of the stator 114 relative to the distal sleeve 120 is maintained. In some embodiments, the positioning element 118 is a separate component, and in other embodiments, the positioning element 118 is a feature of (eg, integrally formed with or coupled to) the stator 114 or the distal sleeve 120 .
[0094] The torque member 122 is connected to the rotor 116 (e.g., via the rotor hub 216) so that when the torque member 122 spins, the rotor 116 also spins. The torque member 122 can be many structures, such as a wire rope, a cable, a tube, a line, or any other suitable structure for spinning the rotor 116. More generally, the torque member 122 has a structure and / or is formed of a material so that the torque member 122 has sufficient torsional stiffness to transmit torque to the rotor 116 while maintaining sufficient bending flexibility to facilitate navigation through the patient's physiological lumen. The torque member 122 can be configured differently according to the specific application to accommodate the need for different flexibility. For example, in applications involving more tortuous or harder physiological lumens, a more flexible torque member can be used, while in applications where the patient's physiological lumen is straighter, larger, or more flexible, a generally harder torque member can be used. The torque member 122 can include a torque member crimping portion 218 at one end, which facilitates connection to the rotor 116 (e.g., connected to the rotor hub 216). In some cases, rotor 116 and torque member 122 are a single component, wherein rotor 116 is molded into, integrally formed with, or coupled to torque member 122 .
[0095] The device 102 may also include a number of radiopaque materials, such as marker bands or components comprised of radiopaque materials, so that the device 102 is visible using fluoroscopy or computed tomography (CT) imaging. For example, the distal end of the device 102 may include a band or strip of material such as tantalum, platinum-iridium alloy, titanium, gold, tungsten, stainless steel, or any other suitable radiopaque material. The marker band may be placed near the distal end of the device 102 to provide feedback to the user about the position of the end. In other embodiments, the stator 114 or the rotor 116 or the distal sleeve 120 may be comprised of a material having a radiopaque additive, such as barium sulfate, bismuth, tungsten, or any other suitable additive.
[0096] Figure 2C and Figure 2D Additional views of the pumping assembly 110 are illustrated and specific dimensions are further indicated. In general, the dimensions of the device 102 can be suitable for many applications and configured (e.g., sized) for a specific application. For example, the device 102 can be configured for thrombectomy of deep vein thrombosis. Due to the relatively large blood vessels and possible clot volume involved in such procedures, embodiments may include an outer diameter OD of the stator OD of ... s The catheter body 104 can be configured from about 1 mm (3 Fr) and including about 1 mm (3 Fr) to about 8 mm (24 Fr) and including about 8 mm (24 Fr). In a specific example, the outer diameter OD s It can be about 5.3mm or 16Fr. The length L of the stators This may also vary in different applications. However, as a non-limiting example, in an application involving the treatment of deep vein thrombosis, L s From about 1 mm and including about 1 mm to about 30 mm and including about 30 mm or about 10 mm.
[0097] The total number of rotations of the stator lumen may also vary. For example, in certain embodiments, the stator helical lumen 210 may include from about 0.5 rotations and including to about 10 rotations and including or about 1 rotation of the stator helical lumen 210.
[0098] The cross-sectional diameter of the rotor is D r However, in certain embodiments, D r It may be from about 0.1 mm and including about 0.1 mm to about 4 mm and including about 4 mm or about 2 mm.
[0099] exist FIG. 2A to FIG. 2D In the embodiment shown in FIG. 2 , the rotor spiral section 214 has a circular profile, however, other geometries are contemplated and within the scope of the present disclosure.
[0100] The stator helical cavity 210 may have a stator pitch P s , and the rotor spiral section 214 may have a length slightly shorter than P s The rotor pitch P r For example, P r It can be P s From about 0.25 times and including about 0.25 times to about 0.75 times and including about 0.75 times or about 0.5 times. For example, the rotor pitch P r can be about 5 mm, and the corresponding stator pitch P s can be about 10 mm, and the length L of the two helical elements s It may be about 10 mm. In such a configuration, the stator helical lumen 210 would have about 1 full turn, while the rotor helical section 214 would have about 2 turns.
[0101] The stator slot 220 can be eccentric to s In certain non-limiting examples, the eccentricity E s It can be from about 0.1 mm and including about 0.1 mm to about 4 mm and including about 4 mm or about 2 mm. Similarly, the rotor spiral section 214 can be made of eccentricity E r Limit. Rotor eccentricity E r It can be the stator eccentricity E s In some embodiments, the rotor eccentricity E r Can be stator slot E sThe eccentricity of the rotor is from about 0.25 times and including about 0.25 times to about 0.75 times and including about 0.75 times or about 0.5 times. In the illustrated embodiment, for example, the rotor eccentricity E r can be about 1 mm, while the stator slot eccentricity E s It may be about 2 mm.
[0102] As previously noted, and as Figure 2D As shown in , the stator 114 and the rotor 116 can be selected to have a spacing gap G between them. In some embodiments, the rotor 116 and the stator 114 have an intentional interference to provide a completely sealed closed cavity 224. In such a case, the spacing gap G can be characterized by a negative value. For example, the spacing gap G can be from about -0.01mm and including about -0.01mm to about -0.5mm and including about -0.5mm or about -0.05mm. Alternatively, the negative spacing gap G can be expressed as a compression percentage as described above.
[0103] In the embodiment where there is an intentional positive spacing gap G between the rotor 116 and the stator 114, the spacing gap G can be characterized by a positive value. For example, the spacing gap G can be from about 0.0 mm and including about 0.0 mm to about 1.0 mm and including about 1.0 mm, or from about 0.05 mm and including about 0.05 mm to about 0.25 mm and including about 0.25 mm or about 0.01 mm. In such an embodiment, the cavity generated between the stator 114 and the rotor 116 is an unsealed cavity. Among other things, the positive spacing gap G (e.g., the non-interference fit between the stator 114 and the rotor 116) can lead to a lower friction between the stator 114 and the rotor 116, making the rotation of the rotor 116 easier, and can allow both the rotor 116 and the stator 114 to be composed of a more rigid material.
[0104] In the illustrated embodiment, each closed cavity 224 formed between the stator helical lumen 210 and the rotor helical segment 214 has a corresponding volume. Although the volume of each cavity can vary depending on the size and geometry of the components of the device 102, in at least some embodiments, the volume of each cavity can be from about 1 μl and including about 1 μl to about 200 μl and including about 200 μl or about 17 μl.
[0105] Since each cavity is formed during rotation of the rotor 116 and represents a fixed volume defined by the space between the rotor helical segment 214 and the stator helical lumen 210 , the flow rate is approximately proportional to the rotational speed of the torque member 122 , which can be adjusted accordingly by the user. Figure 2EAn equation for the approximate flow rate Q of the pumping assembly 110 for a given rotational speed Ω of the rotor in radians per second is provided. For example, in the embodiment shown, the rotor eccentricity E r 1mm, rotor diameter D r is 2mm, and the stator pitch P s 10mm. Based on a rotational speed Ω of 1,000 rpm or 104 rad / s, the flow rate Q is estimated to be approximately 40 cc / min. The design parameters can be adjusted as needed to change the properties of the pump assembly, including the flow rate Q, pump pressure, and other characteristics. The rotational speed of the drive system 130 can be in the range of from about 1 rpm and including about 1 rpm to about 120,000 rpm and including about 120,000 rpm, or from about 2,000 rpm and including about 2,000 rpm to about 60,000 rpm and including about 60,000 rpm or about 15,000 rpm.
[0106] The positive spacing gap between the stator 114 and the rotor 116 can reduce the flow rate of the pumping assembly 110 by allowing the fluid to slide between the spacing gaps. This can beneficially reduce the discharge of viscous materials, such as blood, while still ingesting more viscous or solid / semi-solid materials. In this way, the device 102 can more preferentially remove more viscous materials. Figure 2E The equations in do not take into account the fluid slip that may exist if the closed cavity 224 is an unsealed cavity due to a positive spacing gap between the rotor 116 and the stator 114; however, such an adjustment may be made, for example, by calculation or based on empirical data. It is worth noting that embodiments including a positive spacing gap may not generate significant vacuum pressure, further affecting the flow and intake characteristics of the pumping assembly 110.
[0107] exist FIG. 3A to FIG. 3F , the operation of the pumping assembly 110 is shown in more detail by making the distal sleeve 120 and the stator 114 transparent to observe the movement of the cavity. Figure 3A , the device 102 is shown in an initial configuration. The stator 114 is within the distal sleeve 120, and the rotor helical segment 214 is within the stator helical lumen 210. The rotor hub 216 presses against the positioning element 118 at the proximal end of the stator 114. The torque member 122 is connected to the rotor 116 and moves through the distal bend 206 into the catheter body 104. In this initial configuration, the rotor distal tip 212 is at the top of the slot 220. In some applications, the pumping assembly 110 may have been primed with a fluid such as water, saline, blood, grease, or oil, or conversely, the pumping assembly 110 may be free of material.
[0108] Figure 3B1 is an illustration of the device 102 in an intermediate position with the torque member 122 and the rotor 116 partially rotated. As previously discussed, as the rotor 116 turns, the rotor helical segments 214 interact with the stator helical lumens 210 such that the rotor helical segments 214 are in contact or near contact with the stator helical lumens 210 to define cavities through which material is transported through the pumping assembly 110.
[0109] As shown, the rotor hub 216 interacts with the positioning element 118 to ensure that the rotor 116 is in the correct axial position. More specifically, when the rotor 116 rotates clockwise, the interaction between the rotor 116 and the stator 114 causes a distally directed force on the rotor 116. The positioning element 118 is configured to limit the distal travel of the rotor hub 216 and maintain the distal rotor tip 212 in a desired position at the tissue engaging portion 108. In one embodiment, the distal rotor tip 212 does not significantly extend beyond the stator distal segment 202 to reduce the risk of vascular damage. When the rotor 116 rotates, the rotor distal tip 212 moves downward in the slot 220 at the distal end, and a first open cavity 302 is formed in the space between the rotor 116 and the slot 220. The first open cavity 302 is open to the distal end of the pumping assembly 110, allowing fluid or material to enter the stator 114. The material can be blood or clots or any other material to be removed.
[0110] like Figure 3C As shown in , as the rotor 116 rotates further, the volume of the first open cavity 302 increases as the first open cavity 302 moves proximally into the pumping assembly 110. In some embodiments, this action creates a negative pressure space that draws fluid in like a syringe. In the case of clotted material, the tissue engaging portion 108 can additionally generate mechanical force on the tissue, such as by grabbing or pinching the tissue, and pulling it into the first open cavity 302. Notably, in Figure 3C , the torque member 122 and the rotor 116 have further rotated such that the rotor distal tip 212 is at the bottom of the slot 220. The first open cavity 302 continues to increase in size and moves proximally along the length of the stator 114, thereby further utilizing suction or mechanical force to draw in fluid or material.
[0111] Figure 3D The figure shows that when the rotor 116 further rotates (with Figure 3C104. The device 102 after the rotor 116 and the stator 114 are shown in Figure 106, which moves the rotor distal tip 212 upward and toward its initial position in the slot 220. As shown, the opening of the first open cavity 302 has been reduced as the first open cavity 302 moves into the pumping assembly 110. At the same time, the second open cavity 304 has opened at the distal end of the device 102, and fluid or material begins to be drawn into the second open cavity 304. In the illustrated embodiment, the first open cavity 302 and the second open cavity 304 are separate cavities formed by the contact created between the rotor 116 and the stator 114, and there is limited or no fluid connection between the first open cavity 302 and the second open cavity 304. In other embodiments where there is a spacing gap between the rotor 116 and the stator 114, there may be a small fluid connection between the first open cavity 302 and the second open cavity 304.
[0112] Figure 3E The figure shows that when the rotor 116 further rotates (with Figure 3D Compared to the device 102 after that, the rotor distal end 212 returns to Figure 3A 220. As illustrated, the first open cavity 302 shown in the previous figures has been transformed into a first closed cavity 308, which is no longer exposed to the distal opening of the slot 220 and moves proximally along the pumping assembly 110 within the stator 114 as the rotor 116 continues to rotate. In other words, the first closed cavity 308 is a component volume within the stator 114 that translates along the axis of the pumping assembly 110. In the illustrated embodiment, the first closed cavity 308 is not fluidly connected to the external environment at the distal end of the pumping assembly 110 or the lumen of the catheter body 104. As shown in FIG. Figure 3E As further illustrated in FIG. 1 , second open cavity 304 has become more open to the distal end of pumping assembly 110 , and as a result, fluid or material may be aspirated using vacuum and / or mechanical force.
[0113] Figure 3F The figure shows that when the rotor 116 further rotates (with Figure 3E More specifically, the rotor 116 has rotated another half turn, causing the rotor distal tip 212 to return to the bottom of the slot 220. As shown, the first closed cavity 308 has moved further proximally until it is in communication with the interior volume of the catheter body 104. In other words, the first closed cavity 308 is now pushed into the distal sleeve 120, and as the rotor 116 rotates further, the fluid or material within the first closed cavity 308 will be expelled from the pumping assembly 110 and into the catheter body 104. Figure 3FAs further illustrated in FIG. 1 , the second closed cavity 310 has become completely contained within the stator 114 (e.g., no longer open at the distal end of the pumping assembly 110). Finally, a third open cavity 306 is formed at the distal end of the device 102 between the rotor helical segment 214 and the stator helical lumen 210, thereby allowing material to be ingested into the third open cavity 306.
[0114] by FIG. 3A to FIG. 3F In the manner illustrated in FIG. 1 and discussed above, the rotor 116 can continue to rotate so that additional cavities are formed at the distal end of the device 102, translate through the pumping assembly 110, and open into the catheter body 104, each cavity carrying fluid and / or solid or semi-solid material with it. In other words, fluids and materials can be pumped from the environment distal to the device 102 through the pumping assembly 110 and into the catheter body 104 by the pumping action of the pumping assembly 110.
[0115] Now go to Figure 4 and Figure 5 , an example embodiment of a handle assembly 106 for use with an apparatus according to the present disclosure is shown. Among other things, the handle assembly 106 allows a user to control certain aspects of the functionality of the apparatus 102, which will be described in more detail below. In the illustrated embodiment, the handle assembly 106 includes a catheter hub 124, a drive system 130, a manifold 128, and a housing including two handle shells 126A, 126B. The catheter hub 124 is connected to the catheter body 104 and can be rotated by the user to rotate the catheter body 104, and thereby rotate the distal sleeve 120, the positioning element 118, and the stator 114. Such rotation may be particularly useful when directing the tissue engaging portion 108 having a distal bend 206 toward a specific area of an adherent tissue (e.g., an adherent clot) or a blood vessel. This feature effectively increases the reach of the apparatus 102, allowing larger diameter blood vessels to be processed without the need for a larger apparatus.
[0116] The drive system 130 includes a torque member 122, a torque hub 410, a motor adapter 412, a motor plate 414, a motor 416, a throttle valve 418, a controller 136, and a cable 134. The torque member 122 is housed within the catheter body 104 and enters the handle assembly 106 to engage the drive system 130. The torque member 122 passes through the catheter hub 124 and enters the manifold 128. The manifold includes two sealing members 408A, 408B that prevent fluids and materials from entering the drive system 130. The proximal end of the torque member 122 includes a torque member hub 410 that is configured to be rotated by a motor 416. The motor 416 is attached to a motor plate 414 that holds the motor 416 within the handle shells 126A, 126B. The motor adapter 412 connects the shaft of the motor 416 to the torque member hub 410 so that rotation of the motor 416 causes rotation of the torque member 122. The cable 134 provides power to the motor 416 and may include control inputs or outputs to the device 102. In other embodiments, the cable 134 can be replaced with a battery inside the handle housing 126A, 126B that powers the drive system 130 instead of an external power source. The handle assembly 106 also includes a throttle valve 418 and a controller 136 that allow a user to control aspects of the actuation and / or speed of the motor 416.
[0117] The outlet tube 132 is connected to the manifold 128 and directs fluids and materials out of the handle assembly 106 and to the collection assembly 112 ( Figure 1A In other embodiments, the device 102 can collect fluids and materials in a collection assembly 112 located within the handle assembly 106 or the catheter body 104. In other embodiments, the outlet tube 132 or the collection assembly 112 can incorporate a filter to separate clotted material from the blood and thereby allow the blood to be reintroduced into the patient.
[0118] In some embodiments, the drive system 130 can be manually operated. For example, the motor adapter 412, the motor plate 414, the motor 414, the cable 134 and the throttle valve 418 can be replaced with a mechanism (e.g., a knob, a crank, a handle, a gear, etc.) to facilitate manually driving the rotation of the torque member 122.
[0119] Figure 5 1 is a cross-sectional view of the handle assembly 106. As previously described, the catheter hub 124 is formed from the housing shells 126A, 126B (shell 126B is in the Figure 4 ) and allows the user to rotate the catheter body 104 to guide the tissue engaging portion 108 around the circumference of the blood vessel (e.g., in Figure 1A). Sealing members 408A, 408B housed within the manifold 128 or disposed on opposite ends of the manifold 128 prevent fluid from leaking from the manifold 128. For example, the front sealing member 408A can engage with the catheter hub 124 so that when the catheter hub 124 rotates, the front sealing member 408A maintains a fluid seal within the manifold 128. The rear sealing member 408B can engage with the torque member hub 410 to prevent leakage when the torque member hub 410 spins. Figure 5 As shown in FIG. 4 , the torque member hub 410 and the motor 416 are connected via a motor adapter 412. The outlet tube 132 is connected to the manifold 128 and exits from the handle shells 126A, 126B to the collection assembly 112 ( Figure 1A 4. The throttle valve 418 and the controller 136 may be contained within and held by the handle housing 126A, 126B, for example, in a handle or grip portion of the handle assembly 106.
[0120] In the embodiment shown, the throttle valve 418 is a spring return potentiometer that changes resistance when the user depresses the extension plunger. A line from the potentiometer (not shown) is connected to the cable 134. The cable 134 can lead to a power source or mains. In some embodiments, the controller 136 can exist outside the handle assembly 106 and is adapted to control the rotation and speed of the motor 416 via the cable 134.
[0121] Figure 4 and Figure 5 The handle assembly 106 shown in is intended only as a non-limiting example of a handle that may be used in embodiments of the present disclosure. In general, a handle assembly according to the present disclosure allows a pumping assembly to be actuated, for example, by causing a rotor to rotate within a stator of the pumping assembly. As noted above, additional functionality provided by the handle may include, but is not limited to, rotating the catheter body and providing a passage through which captured fluids and materials may be conveyed, filtered, or otherwise processed. Thus, while Figure 4 and Figure 5 Example embodiments of handle assemblies are provided, but handle assemblies and associated control hubs for use with devices according to the present disclosure are not limited to Figure 4 and Figure 5 The specific configuration shown in .
[0122] FIG. 6A to FIG. 6E The device 102 is illustrated at various stages of use in a clot removal application and, in particular, a thrombectomy procedure. For example, Fig. 6A The process shown in Figure 6F may correspond to thrombus removal for a patient suffering from deep vein thrombosis (where the clot is in the iliofemoral veins) or pulmonary embolism (where the clot is in the pulmonary artery and blocks normal blood flow). FIG. 6A to FIG. 6E The procedures illustrated in the diagram are provided only as examples, and the present disclosure recognizes that FIG. 6A to FIG. 6E The general processes and functions illustrated in the figure can be easily adapted to other clinical applications.
[0123] exist Fig. 6A , the device 102 is shown within a blood vessel 604 having a clot 602 that partially or completely blocks blood flow. In certain applications and procedures, the device 102 may be inserted into the patient's vasculature and navigated to the vessel using standard catheterization techniques and equipment.
[0124] exist Fig. 6A At the point shown in FIG. 1 , the user may, for example, depress the throttle valve 418 ( Figures 4 to 5 102. Actuating the device 102 causes rotation of the torque member 122, which in turn causes the rotor 116 to rotate, thereby activating the tissue engaging portion 108 and the pumping assembly 110, for example, as FIG. 3A to FIG. 3F The tissue engaging portion 108 can engage the clot 602 and begin to ingest blood and material through the pumping assembly 110 and into the catheter body 104 and the outlet tube 132 (e.g., at Figure 1A ).
[0125] In some embodiments, pumping assembly 110 can generate a vacuum pressure or suction flow within vessel 604 that can push clot 602 proximally. In some cases, vacuum pressure can be from about 0.5 inHg and including about 29.2 inHg and including. Alternatively, device 102 can be advanced forward (e.g., toward clot 602) until tissue engaging portion 108 contacts clot 602, such as Figure 6B as shown in .
[0126] exist Figure 6B , the device 102 is advanced so that the tissue engaging portion 108 contacts the clot 602. As the rotor 116 continues to rotate, fragments of the clot 602 can be pulled into the slot 220 by suction flow or mechanical force (e.g., grabbing or pinching the clot 602 or fragments of the clot 602), and subsequently pulled into the open cavity formed by the tissue engaging portion 108 and the pumping assembly 110, as previously discussed. The tissue engaging portion 108, which is composed of tissue contact elements such as the slot 220 and the distal end 212 of the rotor, can mechanically grab the clot and / or loosen the clot by suction. As the cavity moves proximally, the clot 602 also moves through the pumping assembly 110 and is discharged through the catheter body 104 and the outlet tube 132 and into the collection assembly 112.
[0127] exist Figure 6CIn FIG. 6 , the device 102 has removed a portion of the clot 602. The removed portion is within the catheter body 104 and is pumped out of the patient's body as previously described. Fig.6D In FIG, the device 102 is further advanced and more clot 602 has been removed from the blood vessel 604 by the tissue engaging portion 108 and has been ingested into the device 102. Fig. 6E , the clot 602 has been completely removed from the blood vessel 604 and has been removed from the patient's body, for example, by transporting the clot 602 through the catheter body 104, through the handle assembly 106, and into the collection assembly 112 connected to the handle assembly 106.
[0128] exist Figure 7 , an embodiment of the device 102 is shown in an exemplary clinical application. A clot 602 has formed within the iliac vein 704 of a patient. The clot 602 restricts blood flow within the vessel, thereby causing leg swelling and pain for the patient in the patient's lower extremities. Prior to inserting the device 102, an embolic distal protection element 718 may optionally be placed within the inferior vena cava 702 to prevent any displaced or broken portions of the clot 602 from traveling to the heart and lungs. In a specific embodiment, the distal protection element 718 may be an expandable container, such as a braid that captures clot fragments but allows blood to flow. Alternatively, the distal protection element 718 may include a non-porous element, such as a balloon or membrane that completely blocks blood flow. The distal protection element 718 may be inserted through the jugular vein or other appropriate entry site and guided into the inferior vena cava 702 by standard interventional techniques, and may then be expanded within the vessel.
[0129] An introducer sheath 710 can be placed in the popliteal vein 708, which provides access to the patient's venous vasculature proximal to the clot 602. The device 102 can then be inserted into the introducer sheath 710 and guided toward the clot 602 using standard interventional techniques. In some embodiments, a longer introducer sheath or guide catheter is first placed proximal to the clot 602, and the device 102 is then inserted through the sheath or guide catheter. Many methods of navigating the device 102 to the clot 602 can be envisioned. The catheter body 104 extends through the introducer sheath 710, through the popliteal vein 708, through the femoral vein 706, and to the proximal end of the clot 602 within the iliac vein 704.
[0130] In the illustrated embodiment, the collection assembly 112 includes a filter assembly 712. The filter assembly 712 may include a series of meshes, such as mesh 714, which may separate the clot 602 from the blood after being ingested by the device 102. The mesh may have a pore size that may be in the range of from about 1 μm and including about 1 μm to about 500 μm and including about 500 μm, or about 200 μm. In some embodiments, there may be multiple meshes with different pore sizes for removing different component sizes. The filter assembly 712 may include a return tube 716 that is connected to a port on the introducer sheath 710 that allows the separated blood to be reintroduced into the patient's body. In an alternative embodiment, the return tube 716 may be connected to a separate vascular access site. The filter assembly 712 beneficially prevents excessive blood loss in the patient by returning the blood to the vascular system while allowing the removal of clots or other similar materials.
[0131] exist Figure 7 In the exemplary clinical application shown in FIG. 1 , the device 102 is actuated by a user using a corresponding control (e.g., a throttle valve 418 of the handle assembly 106), and as shown in FIG. FIG. 3A to FIG. 3F
[0066] The clot material and blood are removed from the patient as described in. After removing some or all of the clot 602, the device 102 and distal protection element 718 may be removed.
[0132] In other embodiments, the device 102 can access the clot 602 from above (i.e., in the opposite direction) via an access site in the jugular vein. In such embodiments, the distal protection element 718 can optionally be configured to be located on the catheter body 104 or the distal sleeve 120. Alternatively, the device 102 can be inserted through the distal protection element 718 by, for example, incorporating it into the introducer sheath 710 or guide catheter.
[0133] exist Figure 8 In the present invention, a method 800 for treating a patient to remove material from a lumen or cavity is provided. In step 802, a device according to the present disclosure is inserted into the patient and positioned into the lumen or cavity containing the material.
[0134] In step 804, the device may be advanced proximate to or into contact with the material, depending on whether suction will be used to draw the material into the tissue engaging portion of the device.
[0135] In step 806, the device is actuated to begin taking material into the device. In certain embodiments, actuating the device may include actuating the pumping assembly of the device. As previously discussed, such actuation may engage the material and begin to draw the material into the catheter body of the device. For example, in an embodiment in which the device is contacted with the material in step 804, actuating the pumping assembly may cause the pumping assembly to mechanically engage the material. Instead of or in addition to mechanical engagement and delivery, actuating the pumping assembly may also produce suction that draws the material into the pumping assembly. Finally, actuation of the device may also or alternatively include applying a separate suction source to draw the material near or in contact with the tissue engaging portion of the device. The material may then be further captured by actuating the pumping assembly of the device, for example, by mechanical engagement or aspiration / suction.
[0136] In step 808, the material is ingested into the device and thereby partially or completely removed from the lumen or cavity by repositioning the tissue engaging portion or pumping assembly as needed. This may include advancing or retracting the device and / or rotating the tissue engaging portion or pumping assembly via the catheter hub.
[0137] The removed blood and material is typically collected for disposal in step 810. Collection for disposal may include filtering the material from other fluids (eg, blood) to remove particles and allow the fluid (eg, blood) to be reintroduced into the patient.
[0138] In step 812, the device is removed from the lumen or cavity in the patient, thereby substantially completing the clinical procedure.
[0139] In some embodiments, the pumping assembly 110 may be FIG. 3A to FIG. 3F The exemplary embodiment shown in is longer. For example, in FIG. 3A to FIG. 3F In the embodiment shown in FIG. 1 , the stator helical lumen 210 has approximately one rotation, which allows the rotor 116 to form a single closed cavity 224 within the stator 114. For purposes of this disclosure, such an arrangement is generally referred to as a single-stage pump / single-stage pumping assembly.
[0140] Reference Figure 2C and Figure 2D In other embodiments, the stator length L can be increased by s and the number of rotations within the stator helical cavity 210 and / or by reducing the stator pitch P s Such modifications may increase the number of closed cavities 224 formed by the rotor 116 and stator 114 during operation. Among other things, additional stages of the pump may allow the pumping assembly 110 to generate higher head pressures than a single-stage embodiment.
[0141] With the foregoing in mind, in some embodiments, the pumping assembly 110 includes at least a single stage; however, in other embodiments, the pumping assembly 110 may include any suitable number of stages, including but not limited to two (2) stages, three (3) stages, or up to five (5) stages. In still other embodiments, the pumping assembly 110 may include more than five (5) stages, for example, up to 100 stages. In the latter embodiment, the pumping assembly 110 may extend along a majority of the catheter body 104 up to the entire length. In other embodiments, the pumping assembly 110 may not include a complete single stage, such that the stator helical lumen 210 has less than one helical turn.
[0142] Fig. 9A and Fig. 9B Additional embodiments of the present disclosure are illustrated. Fig. 9A , the stator spiral lumen 210 and the rotor spiral segment 214 form three (3) closed cavities. Among other things, a stator / rotor configuration including more cavities can achieve higher pressures and can allow for a reduced compression seal or spacing gap between the rotor 116 and the stator 114 so that the formed cavities are unsealed cavities.
[0143] Fig. 9A An example device is illustrated in the front view shown where the rotor distal tip 212 is generally circular and the stator helical lumen 210 approximates an oblong slot 220. In contrast, Fig. 9B An alternative embodiment is illustrated in which the profile of the rotor distal tip 212 has an oval shape and the stator helical lumen 210 approximates a triangular slot 220 with rounded corners. Such a configuration can create multiple open cavities in the tissue engaging portion 108, as shown by the first open triangular cavity 902 and the second open triangular cavity 904, among other things. Fig. 9B The embodiment shown in FIG. 1 includes ten (10) closed cavities along its length, while having a ratio of Fig. 9A The embodiment shown in has a shorter pitch.
[0144] More generally, the stators and rotors of embodiments of the present disclosure can be configured to form any number of cavities during operation. For example, in certain embodiments, the stators and rotors can be configured to form from and including a single cavity to and including about 200 cavities. Embodiments including a relatively high number of cavities can be facilitated by extending the stator 114 a substantial proportion of the length of the catheter body 104 up to the entire length of the catheter body 104 with the stator helical lumen 210 and the rotor helical segment 214 extending therethrough. In other embodiments, the rotor helical segment 214 can be longer than the stator helical lumen 210 so that it extends out of the proximal end of the stator 114 into the distal sleeve 120 or the catheter body 104.
[0145] Fig. 10A and Fig. 10B Another alternative embodiment of the device 102 is shown. More specifically, in Fig. 10A and Fig. 10B In the example of , the distal sleeve 120 is generally straight and in line with the axis of the catheter body 104. This is in contrast to some of the previously discussed embodiments in which the device 102 includes a distal bend. Fig. 10A and Fig. 10B In a specific example of the embodiment shown in FIG. , the length L of the stator s may be approximately 20 mm long, and the rotor 116 may include a rotor spiral section 214 and a rotor hub 216 ( Fig. 10B ) between the short straight sections. Fig. 10B The rotor hub 216 is also illustrated as including helical cutouts that may advance ingested material into the catheter body 104 during operation / rotation of the rotor 116 .
[0146] FIG. 11A to FIG. 11C Picture shows Fig. 10A and Fig. 10B 108. As illustrated, the rotor hub 216 engages with the positioning element 118, which is shown as an integral part of the distal sleeve 120. The positioning element 118 feature axially positions the rotor 116 relative to the stator 114 so that the rotor distal tip 212 is flush with the end of the stator distal segment 202 at the tissue engaging portion 108. Fig.11A , the pumping assembly 110 is in an initial configuration with the rotor distal tip 212 at the top of the slot 220. At the slot 220, the space between the rotor helical segment 214 and the stator helical lumen 210 creates a first open cavity 302 that is open to the distal end of the device 102, allowing fluids and materials to enter the first open cavity 302.
[0147] exist Fig. 11BIn the embodiment, the rotor 116 is relative to Fig.11A 20. The configuration shown in FIG. 20 is rotated about a quarter turn. As a result of the rotation, the rotor distal end 212 has moved down to about half of the open slot 220. As the cavity volume moves into the pumping assembly 110, the opening to the first open cavity 302 is reduced. The second open cavity 304 has been opened, and fluid or material can similarly enter the cavity. The first open cavity 302 and the second open cavity 304 can be discrete fluid spaces that are partially or completely sealed from each other.
[0148] exist Fig. 11C In the embodiment, the rotor 116 is relative to Fig. 11B 104. The configuration shown in FIG. 104 is rotated another quarter turn. As a result, the rotor distal tip 212 is now located at the bottom of the slot 220. The first closed cavity 308 is no longer substantially connected to the distal end of the device 102 and has moved completely within the stator 114. The second open cavity 304 is now completely open to the distal end of the pumping assembly 110, and fluid or material continues to be taken up into the cavity. As the rotor 116 continues to rotate, the first closed cavity 308 will be pumped into the catheter body 104, and then the second open cavity 304 will also be pumped into the catheter body 104. This process continues, forming a new cavity at the stator distal section 202, which is then taken up into the stator 114 and pumped into the catheter body 104. Therefore, the assembly works like a progressive cavity pump, taking material into the stator 114 and discharging it into the catheter body 104.
[0149] exist Fig. 12A and Fig. 12B , an embodiment of a device 1200 of the device 102 is shown that includes one or more additional channels 1202, 1204 in the tissue engaging portion 108 to facilitate infusion and / or aspiration. More specifically, and compared to the previous embodiments, the stator distal segment 202 is modified to include one or more additional channels that are fluidly connected to the catheter body 104.
[0150] exist Fig. 12A In FIG. 1 , a suction inlet 1202 is shown from which material can be removed and an infusion outlet 1204 is shown from which material can be delivered. Fig. 12B In the exploded view, the Fig. 12A. As shown, the stator 114 has a channel along its outer surface that allows direct fluid communication between the distal end of the device 102 and the catheter body 104. In some embodiments, these channels are lumens extending through the stator 114 or the distal sleeve 120. The suction channel 1206 connects the suction inlet 1202 and the suction outlet 1210 in the distal sleeve 120. The infusion channel 1208 connects the infusion outlet 1204 to the infusion inlet 1212 in the distal sleeve 120. The suction channel 1206 can be used to apply suction through a separate connected suction source (such as a pump or syringe), which can move and hold the clot to the tissue engaging portion 108 while the pump assembly destroys and ingests the clot. For example, a suction syringe can be connected to the outlet tube 132, and the outlet tube 132 is connected to the suction inlet 1202 through the suction channel 1206 fluid. When vacuum pressure is applied via the syringe, fluid can flow through the suction inlet 1202, which can allow the device 102 to draw material into the device or hold it there while the tissue engaging portion 108 and the rest of the pumping assembly 110 remove the clot. In this way, the suction inlet 1202 can be an integral part of the tissue engaging portion 108.
[0151] Likewise, the infusion inlet 1212 can be connected to a tube that allows a user to inject material into the distal end of the device 102 through the infusion channel 1208. For example, a developer can be injected into the front of the device 102. Alternatively, a drug or any other clinically appropriate material can be injected. In other embodiments, saline can be injected through the infusion outlet 1204. This can be beneficial to provide a low viscosity fluid for the pumping assembly 110 to help clot extraction and reduce blood loss. Alternatively, the infused saline can be used to pressurize the blood vessel so that the blood vessel does not collapse due to the negative pressure generated by the pumping assembly 110 or a separate suction source. The infused saline can also be used to help the tissue joint portion 108 to absorb the material. The pumping assembly 110 can work better when a more viscous material is mixed with a viscous fluid such as water, saline or blood. The infused fluid can also be sprayed at high speed to provide a more viscous material at the tissue joint portion 108, and thereby improve the uptake performance. In some embodiments, the infused fluids may include saline and glucose, which may be used to flush blood out of the vessel to improve clot visualization using techniques such as optical coherence tomography (OCT).
[0152] An extrusion or tubing within the catheter body 104 can be used to connect the suction outlet 1210 and the infusion inlet 1212 fluid to the handle assembly 106. In the illustrated embodiment, channels 1206 and 1208 are formed between the stator 114 and the distal sleeve 120, and are spirally wound around the stator 114 to avoid the stator spiral lumen 210. In other embodiments, the channel can be straight or in another non-spiral pattern. In other embodiments, the two channels can be suction channels 1206 or infusion channels 1208, or the device 102 can have only one channel or more than two channels. In other embodiments, the channel can be used to insert a guidewire or other device useful in a standard catheter procedure. For example, a guidewire can be inserted through one of the channels and used to deliver the device to a position within a patient's lumen or cavity.
[0153] FIG. 13A to FIG. 13B An alternative embodiment of an apparatus 1300 according to the present disclosure is illustrated. More specifically, and in contrast to the previously illustrated embodiments, the apparatus 1300 is shown as having a stator 114 of uniform wall thickness. Fig.13A , the distal end of the device 102 is shown, which includes two stator supports 1302. The catheter body 104 extends over the entire distal end of the device 102 and contains the stator supports 1302 without the distal sleeve 120.
[0154] exist Fig. 13B In the exploded view, the Fig.13A Device 1300. As shown, the stator 114 has a stator spiral lumen 210 and a slot 220 similar to those in the previous embodiment. However, in contrast to the previously discussed embodiments, the outer profile of the stator 114 is not cylindrical. Instead, the outer profile of the stator 114 matches the stator spiral lumen 210 so that a substantially uniform wall thickness is maintained throughout the stator 114. The wall thickness can vary depending on the overall size and clinical use of the catheter; however, in certain example embodiments, the wall thickness can be from about 0.1 mm and including about 0.1 mm to about 10 mm and including about 10 mm, from about 0.2 mm and including about 0.2 mm to about 1 mm and including about 1 mm, or about 0.4 mm.
[0155] The stator support 1302 generally includes an inner surface that matches the outer profile of the stator 114. When the rotor 116 spins within the stator 114, the stator spiral lumen 210 is compressed between the rotor spiral section 214 and the stator support 1302. Because the stator 114 has a generally uniform wall thickness, the compression and sealing performance can be maintained along the entire spiral contact line. However, the present disclosure contemplates that other outer profiles of the stator 114 are possible, and particularly contemplates embodiments in which the stator 114 may not have a uniform wall thickness.
[0156] The device 1300 also includes suction channels 1206 extending on the outer surface of the stator support 1302. This configuration of the suction channels 1206 may be beneficial because they are present in the stator support 1302 and therefore do not affect the sealing of the stator 114. In some embodiments, the stator support 1302 material can be harder than the stator 114 material, for example, the stator support 1302 can be formed of a hard plastic or metal, while the stator 114 can be formed of an elastomeric material. Alternatively, each of the stator supports 1302 can be formed of an elastic material (such as silicone or polyurethane) that is harder than the stator 114 material.
[0157] The stator support 1302 includes locating features 1304 for interacting with the rotor hub 216. In the illustrated embodiment, the locating features 1304 provide both distal and proximal locating elements 118 for the rotating hub 216. Such locating features 1304 may be incorporated into any of the embodiments described herein. Fig. 13B Embodiments also include an auger feature 1306 extending along the torque member 122. The auger feature 1306 can, among other things, help push fluids and materials proximally within the catheter body 104 and reduce occlusion of the lumen of the blocked catheter body 104. The auger feature 1306 can be a separate component surrounding the torque member 122, or can be integrally formed with the torque member 122.
[0158] FIG. 14A to FIG. 14H Several alternative embodiments of the tissue engaging portion 108 of a device according to the present disclosure are illustrated. Fig.14A, the tissue engaging portion 108 includes an extension feature 1402 that extends beyond the end of the stator 114. The rotor distal tip 212 is therefore concave, which can be beneficial to prevent damage to blood vessels, etc. The length of the extension feature 1402 can vary; however, in certain example embodiments, the extension feature 1402 can be from about 0.1 mm and including about 0.1 mm to about 100 mm and including about 100 mm, from about 1 mm and including about 1 mm to about 10 mm and including about 10 mm, or about 2 mm. As shown, the extension feature 1402 can be formed by the distal sleeve 120. Alternatively, the extension feature 1402 can be formed by the catheter body 104, or can be a separate component connected to the distal sleeve 120. Although shown as being substantially cylindrical, in other embodiments, the extension feature 1402 can end with a beveled end or be non-cylindrical. In other embodiments, the extension feature 1402 can be expandable and include a braid, laser cut component, or similar structure that forms a cage around the rotor distal tip 212 and the stator distal segment 202 to provide a barrier to prevent blood vessels or other tissue from being ingested into the pumping assembly 110. In other embodiments, the extension feature 1402 can be slidably or rotatably adjustable relative to the pumping assembly 110. For example, an outer tube on the device 102 can be used to increase or decrease the amount that the distal side of the stator 114 is recessed within the extension feature 1402. In yet other embodiments, the pumping assembly 110 can be positioned anywhere along the length of the catheter body 104, such that the extension feature 1402 is only the portion of the catheter body 104 that extends distally of the pumping assembly 110. For example, the pumping assembly 110 can be positioned within the catheter body 104 midway along the length of the catheter body 104.
[0159] Fig. 14B Another embodiment of the device 102 is illustrated that includes a funnel feature 1404 on the tissue engaging portion 108. The funnel feature 1404 can, among other things, help direct fluids and materials into the stator helical lumen 210, or can alternatively provide a suction cup feature for securing material to the tissue engaging portion 108 during uptake.
[0160] exist Fig. 14C, the rotor distal tip 212 includes a rotor tip extension 1406 extending forward into the funnel feature 1402. The rotor tip extension 1406 can help the tissue engaging portion 108 break and ingest material into the stator 114. The rotor tip extension 1406 can have a pointed geometry as shown, or can be many other shapes and configurations, such as an auger shape or a paddle shape. In some embodiments, the rotor tip extension 1406 can remain within the extension feature 1402 or can extend beyond the distal end of the device 102. In some embodiments, the rotor tip extension 1406 can be advanced or retracted by the user. For example, the rotor 116 can be advanced forward during certain portions of the operation to extend the rotor tip extension 1406 to help break the clot and remove wall-adherent clots. During this operation, the handle assembly 106 can rotate the rotor 116 at a slower speed to prevent vascular damage. The rotor 116 may then be retracted so that the rotor distal tip 212 is flush with the end of the stator 114 and the risk of vessel damage is minimized, which may allow for faster motor rotation speeds.
[0161] exist Fig.14D In the embodiment of the present invention, the rotor 116 has a spiral lumen extending through the length of the rotor 116, which allows an extension wire 1408 or a similar elongated structure to pass through the rotor 116. The extension wire 1408 can be pushed out of the end of the rotor 116 to form a pushable rotor end extension 1406 in the tissue engaging portion 108. The extension wire 1408 can include a predetermined shape such as a curve or a hook, which is configured to contact the vessel wall and disrupt the clot. The motor speed of the handle assembly 106 can be controlled depending on whether the extension wire 1408 is extended. In some embodiments, the extension wire 1408 is non-adjustable and is an integral part of the rotor 116. Alternatively, the extension wire 1408 can be used as a guide wire for navigating and delivering the device 102 to the target site.
[0162] exist Fig.14E 14, the distal sleeve 120 includes a capped end 1410 that can beneficially prevent the tissue engaging portion 108 from ingesting vessel walls, valves, or other tissue that is not intended to be removed by the device 102. The distal sleeve 120 also includes a side cutout 1412 that can direct material from the side into the tissue engaging portion 108. This can be particularly useful for material present on the luminal wall of a vessel. In this embodiment, the side cutout 1412 can be circumferentially rotated using a mechanism such as the catheter hub 124.
[0163] exist Fig.14FIn the embodiment of the present invention, the tissue engaging portion 108 includes a series of thrombus holders (e.g., holder 1414) protruding from the distal end of the stator 114. The gaps between adjacent thrombus holders can form one or more fluid inlets (e.g., fluid inlet 1416). The fluid inlet can allow low viscosity fluids (such as blood) to still enter the pumping assembly 110 while more viscous materials are ingested. This can beneficially enable the pumping assembly 110 to ingest a mixture of blood and thrombus, rather than just thrombus, which can improve the performance of the pumping assembly 110.
[0164] exist Figure 14G , the tissue engaging portion 108 includes an infusion outlet 1204 in the stator 114. The infusion outlet 1204 can be used to inject a fluid (such as saline), which can provide improved performance of the pumping assembly 110. The injected fluid can ensure that the pumping assembly 110 has an optimal mixture of low viscosity materials and high viscosity materials. In addition, the infusion outlet 1204 can be directed at an angle and used to eject viscous materials at high speeds. This can be beneficial in breaking up viscous materials such as thrombi before being ingested by the pumping assembly 110. The infusion outlet 1204 can be directed at an angle or perpendicular to the end of the stator 114.
[0165] exist Fig.14H , tissue engaging portion 108 includes an infusion outlet 1206 through rotor 116. For example, rotor 116 can have a lumen extending through its center and connected to a hollow torque member such as a tube or torque coil. The injected fluid can contribute to the performance of pumping assembly 110. Alternatively, the injected fluid can include contrast media, fluid with an active pharmaceutical ingredient (API), or many other desired fluids.
[0166] Any combination of features or elements of the foregoing embodiments may be used alone or in combination with other embodiments discussed herein. For example, rotor tip extension 1406 may be present within capped end 1410 such that it disrupts clots prior to ingestion into pumping assembly 110, but with limited risk of vessel damage due to rotor tip extension 1406 being contained within distal sleeve 120.
[0167] Fig.15A and Fig. 15B An embodiment of the device 102 is illustrated that includes a guidewire 1502. Generally, the device 102 is delivered through the patient's vasculature to the material to be removed. Certain catheterization techniques involve advancing the device over a guidewire or a smaller catheter. Fig.15A and Fig. 15BIn the illustrated embodiment of the invention, the guidewire 1502 is inserted through the access hole 1504 near the distal bend 206 of the distal sleeve 120. The access hole 1504 is generally sized to accommodate any suitable guidewire or microcatheter; however, in at least some embodiments, the access hole 1504 can have a diameter from about 0.008 inches and including about 0.008 inches to about 0.080 inches and including about 0.080 inches or about 0.035 inches. This beneficially allows the guidewire 1502 to be navigated and placed in the correct position within the patient's vasculature, and then the device 102 can be advanced over the guidewire 1502 to the target site. With the distal bend 206, the pumping assembly 110 is offset from the axis of the catheter body 104 and the guidewire 1502, so that the lumen of the pumping assembly 110 does not need to avoid the guidewire 1502 in order for the device 102 to travel along the guidewire 1502. In some embodiments, additional exit holes may be present on the catheter body 104 or distal sleeve 120, which allows for rapid replacement of the catheter. Once the guidewire 1502 is in place, the proximal end of the guidewire 1502 can be fed through the entry hole 1504 and then out of the exit hole in the catheter body 104. In this way, the guidewire 1502 does not need to be too long.
[0168] The present disclosure contemplates other methods of navigating the device 102 on the guidewire 1502. In some embodiments, the rotor 116 can be removed from the stator 114 so that the guidewire 1502 can pass through the lumen created by the stator spiral lumen 210. Once at the target site, the guidewire 1502 can be removed and the rotor 116 can be inserted into the stator 114. In other embodiments, the rotor 116 and / or the torque member 122 can include a hollow lumen passing through its center, which can allow the guidewire to pass. In such an embodiment, the proximal end of the guidewire 1502 can be inserted through the rotor 116 and the torque member 122 to enable navigation of the device 102, and then the guidewire 1502 can be removed. In other embodiments, the guidewire 1502 can be reinstalled into the channel 1206 so that the device 102 travels along the guidewire 1502, which is spirally wound around the stator 114 within the distal sleeve 120.
[0169] exist Fig. 15C , an embodiment of the device 102 having a plurality of distal bends 206 is shown. The plurality of distal bends 206 allow the axis of the stator 114 to remain relatively parallel to the axis of the catheter body 104 but offset so that rotation of the catheter body 104 moves the tissue engaging portion 108 within the vessel. Such an embodiment can achieve an improved reach of the device 102 within a large vessel without adversely directing the tissue engaging portion 108 toward the vessel wall. Any number of other suitable bends and orientations of the stator 114 relative to the catheter body 104 are contemplated.
[0170] exist FIG. 16A to FIG. 16C , an embodiment of the device 102 is shown having a visualization component 1602 at the distal end of the stator 114. The stator opening 1606 can hold and / or orient the visualization component 1602 to face forward and can be offset from the stator spiral lumen 210, minimizing the increased catheter size of the device 102 having the visualization component 1602. In addition, the visualization cable 1604 can be primarily straight as it travels along the length of the stator 114. In some embodiments, the visualization component 1602 can be advanced or rotated forward and backward relative to the stator 114 to change the viewing angle. The visualization component 1602 can be a camera such as a CMOS or CCD imaging device that provides visual feedback to the user about the tissue structure at the distal end of the device 102 or about the clot 602 in the blood vessel 604. Alternatively, the visualization component 1602 can be an intravascular ultrasound (IVUS) imaging probe or catheter. Alternatively, the visualization component 1602 can be an optical coherence tomography (OCT) element. For example, the OCT element can be a guidewire that can be advanced from the end of the device 102. The head of the visualization component 1602 can have a diameter of from about 0.25 mm and including about 0.25 mm to about 3.0 mm and including about 3.0 mm, from about 0.5 mm and including about 0.5 mm to about 2.0 mm and including about 2.0 mm, or about 1.0 mm. Alternatively, the head of the visualization component 1602 can be a rectangular profile.
[0171] The head of the visualization assembly 1602 can be connected to a visualization cable 1604, which extends inside the catheter body 104 and outside the patient's body. The visualization assembly 1602 can include a display such as an LCD or LED screen to provide visual feedback to the user. In some embodiments, the user can watch the display and advance or rotate the device 102 accordingly so that the distal end of the catheter is guided toward the desired tissue such as a clot. Visual feedback can help the user navigate the end of the device away from the vessel wall, venous valve or other important tissue structure or avoid activating the device 102 near the vessel wall, venous valve or other important tissue structure. In addition, visual feedback can indicate to the user when the blood vessel collapses due to negative pressure or excessive suction flow generated by the device 102.
[0172] In some embodiments, the information provided by the visualization component 1602 can be used by software within a computing device that communicates with the device 102 or executed by the computing device. For example, if the software detects that the distal end of the device 102 is too close to a tissue structure such as a blood vessel wall or a venous valve, the software can disable the device 102. In other embodiments, the software can create an alarm or alert to the user in such a case. In some embodiments, the software can help the user navigate to the material by providing an auditory or visual indication. In other embodiments, various aspects of the device 102 can be automatically controlled by, for example, the orientation of the distal end, the advancement of the distal end in the blood vessel, and the activation of the pumping assembly 110. In this way, the visualization component 1602 can implement more automated aspects of the program by providing feedback to the software. In some embodiments, the visualization component 1602 can provide feedback to the user about the location of the clot 602 in the blood vessel 604. For example, if the user moves the device 102 through the blood vessel 604, some clots 602 can be removed, but some clots 602 may remain, especially wall-adherent clots 602. The visualization assembly 1602 can indicate to the user where to direct the tissue engaging portion 108 of the device and thereby provide more targeted removal of the clot 602. In some embodiments, the visualization assembly 1602 can be advanced through the vessel 604 and then withdrawn and a 2D or 3D representation of the vessel 604 can be displayed to the user. In some embodiments, the visualization assembly 1602 is not at the distal-most tip of the device 102, but rather is along the side of the pumping assembly 110 or within the catheter body 104.
[0173] exist 17A to 17C, an embodiment of the device 102 is shown having a first visualization component 1602 and a second visualization component 1608 helically wound around the stator 114. By winding the first visualization cable 1604 and the second visualization cable 1610 around the stator 114, the overall size profile of the device 102 is not increased or minimally increased. In some embodiments, the first visualization component 1602 is a camera and the second visualization component 1608 is an IVUS probe. In other embodiments, both components can be cameras and provide stereoscopic vision. In other embodiments, the visualization components can be directed at different angles or provide different depths of focus. The second visualization component 1608 does not necessarily need to be an imaging element. It can also be a light source for the first visualization component 1602 or for external visualization through the patient's skin to achieve direct visualization of the device 102. In other embodiments, the second visualization component 1608 can be a tube for delivering materials that will facilitate visualization to the distal end of the device. For example, the second visualization component 1608 can deliver saline or other light-transmitting fluid that is transparent to the first visualization component 1602 and can provide positive pressure within the blood vessel to maintain the patency of the blood vessel and prevent collapse. In other embodiments, the visualization component 1602 does not necessarily require the visualization cable 1604 and can include communication electronics for transmitting information to the display or software of the device 102 using Wi-Fi, Bluetooth, or any other suitable method.
[0174] exist 18A to 18E , an embodiment of the device 102 is shown having an aspiration catheter 1802. The aspiration catheter 1802 is inside a blood vessel 604 having material to be removed, in this case a clot 602 that is blocking blood flow.
[0175] exist Fig.18B In the embodiment, the suction catheter 1802 is advanced to the clot 602, and the suction source is connected to the catheter that engages the clot 602. As shown, the clot 602 has a plugged portion 1804 within the suction catheter 1802. In this configuration, the vacuum level can be intentionally reduced to prevent ingestion of the clot 602. Alternatively, Fig.18B The situation illustrated in FIG. 14 may be caused by the maximum vacuum level of the aspiration catheter 1802 being insufficient to completely ingest the clot 602 .
[0176] exist Fig. 18CIn the embodiment of the present invention, a version of the device 102 is inserted through the lumen of the aspiration catheter 1802 and advanced to the clot 602 to facilitate further uptake of the clot 602. As described throughout this disclosure, the device 102 can be configured to abut or be disposed proximal to the clot 602 and then activated to, for example, use one or both of mechanical engagement with the clot 602 and aspiration to uptake the clot 602 into the device 102. For example, in the embodiment of the present invention, the device 102 can be configured to abut or be disposed proximal to the clot 602 and then be activated to uptake the clot 602 into the device 102 using mechanical engagement with the clot 602 and aspiration. Fig.18D In, clot 602 has been partially taken up into device 102, and in Fig.18E , clot 602 has been completely removed from blood vessel 604.
[0177] In some embodiments, the device 102 can be a suction source for the suction catheter 1802 and can generate a vacuum level to engage the clot 602 to the end of the suction catheter 1804. In such an embodiment, the pumping assembly 110 can be disposed within the suction catheter 1802 at a distance from about 0 cm and including about 0 cm to about 100 cm and including about 100 cm, or from about 0.1 cm and including about 0.1 cm to about 20 cm and including about 20 cm, or about 0.5 cm away from the distal end. When the device 102 is activated, suction is formed within the suction catheter 1802, which pulls the clot 602 into the suction catheter 1802 and up to the tissue engaging portion 108. The clot 602 is then taken up into the pumping assembly 110 and expelled into the lumen of the catheter body 104 or the lumen of the suction catheter 1802. The position of the pumping assembly 110 can be adjusted as needed, and in some embodiments can be advanced beyond the end of the aspiration catheter 1802. In this way, the user can adjust the position of the tissue engaging portion 108 according to the type of clot, the stage of the procedure, or any other reason. In some embodiments, the aspiration catheter 1802 can be tightly fitted to the outer diameter of the device 102, so that the catheter forms a slidable outer tube on the device 102, which can engage the clot 602 and can also push the clot away from the end of the device 102 to prevent or remove the blockage of the pumping assembly 110. In other embodiments, the outer diameter of the device 102 can be smaller than the internal lumen of the aspiration catheter 1802, so that the fluid can bypass the lumen of the device 102. In some embodiments, the catheter body 104 is replaced by a control wire that can advance, retract or rotate the pumping assembly 110. Therefore, the lumen of the aspiration catheter 1802 can be maximized along its length, and the delivery ability of the device 102 through the aspiration catheter 1802 can be improved.
[0178] exist FIG. 19A to FIG. 19C In FIG. 1 , an embodiment of an apparatus 102 including a filter assembly is shown. Fig.19A, an alternative embodiment of a handle assembly 106 having a catheter hub 124, a throttle valve 418, and two handle shells 126A, 126B is shown. The outlet tube 132 is connected to the collection assembly 112 having a filter assembly 712 and a collection cap 1902.
[0179] exist Fig.19B , the same device 102 is shown with the collection assembly 112 in a disassembled state. During operation, material removed using the device 102 enters the collection assembly 112 and is then filtered through the filter assembly 712. By doing so, solid or semi-solid materials (e.g., thrombotic materials) are retained in the front region of the collection chamber, and lower viscosity materials travel to and are separated into the rear region of the collection assembly 112. In some embodiments, the collection assembly 112 can be at least partially transparent to provide a visual indication of the operation of the device 102 and the corresponding capture of materials within the collection assembly 112. In some embodiments, the collection cap 1902 can also include a separate port for infusion, which allows the user to inject fluid (e.g., saline) so that the material in the front region of the collection assembly 112 can be better visualized. In addition, the filtered blood can be stored for reintroduction into the patient when necessary. In some embodiments, the collection assembly 112 can be integral with the handle assembly 106 so that the outlet tube 134 can be omitted.
[0180] exist Fig.19C In the embodiment, the device 102 includes a series of filters for separating solid or semi-solid materials from blood or other fluids and a return tube 716 for reintroducing fluid into the patient's body. In a specific embodiment, the first filter assembly 712 can have a pore size from about 25 μm and including about 25 μm to about 1000 μm and including about 1000 μm, from about 100 μm and including about 100 μm to about 400 μm and including about 400 μm or about 200 μm. In the same embodiment, the second filter assembly 1904 can have a pore size from about 5 μm and including about 5 μm to about 100 μm and including about 100 μm or about 40 μm. However, more generally, any number of additional filters and filter pore sizes can be implemented. In addition, the return tube 716 can feed blood back to the patient through any number of entry points (such as an introducer sheath, a separate entry site) or through the catheter body 104.
[0181] exist Fig. 206, the device 102 is shown to remove wall adherent material 2002. In certain disease states, material adheres to the wall of the blood vessel 604. The material can include certain thrombotic diseases such as DVT, and can also include plaque found in peripheral artery disease and coronary artery disease. The wall adherent material 2002 can be difficult to remove with a straight catheter body 104. In this embodiment, the catheter body 104 includes a distal bend 206 and can be positioned using rotation 2004 of the catheter body 104. Such a device 102 can advantageously access the entire circumference of the blood vessel 604.
[0182] As an alternative or supplement to the previously discussed proximal filtering and separation system, the device 102 can also include a catheter filter 2006 along the catheter body 104. The catheter filter 2006 can include a series of holes in the catheter body 104, as shown, or can alternatively include a separate filter material. When blood and material are discharged from the pumping assembly 110 and pushed through the catheter body 104, blood can be filtered from the material and can re-enter the blood vessel 604 by the filtered blood backflow 2008. This can advantageously reduce the amount of blood removed. The catheter filter 2006 can include a variety of hole sizes and lengths.
[0183] exist Fig.21 , an alternative embodiment of the device 102 is illustrated in which the tissue engaging element 108 includes an expandable funnel 2010. The expandable funnel 2010 can be collapsed in the delivery sheath during introduction into the blood vessel 604. Once deployed, the expandable funnel 2010 can be opened in the blood vessel 604 and provide a partial or complete flow retardation in the blood vessel 604. This can advantageously help the tissue engaging element 108 to pull the material toward the pumping assembly 110 and can reduce the possibility of particles flowing downstream of the treatment site. In certain embodiments, the expandable funnel 2010 can be composed of braided wire or laser cut tubing, and can additionally include a membrane such as silicone or PTFE that makes the expandable funnel 2010 impermeable or semi-impermeable.
[0184] Fig. 22An alternative embodiment of the device 102 is illustrated, wherein the pumping assembly 110 is disposed within the handle assembly 106. More specifically, the pumping assembly 110 shown is a progressive cavity pump that includes a stator 114 and a rotor 116, and its operation is described herein. The handle assembly 106 has a motor 416 that is rotationally connected to a motor adapter 412, and the motor adapter 412 is then rotationally connected to the rotor 116. A manifold 128 fluidly connects the inlet of the pumping assembly 110 to the catheter body 104 so that the operation of the pumping assembly 110 draws fluid from the catheter body 104. The distal end of the catheter body 104 can be open and thus work like a conventional suction catheter. Beneficially, such an embodiment can eliminate the need for a separate piece of equipment and create a vacuum closer to the end of the catheter, resulting in less line loss and greater dynamic control for the user. In the illustrated embodiment, an outlet tube 132 empties the fluid into a waste container, and a cable 134 provides power to the device 102. In other embodiments, the waste container can be integrated into the handle assembly 106 with the battery so that no additional cables or lines extend from the device 102. In some embodiments, the distal end of the catheter body 104 can still include an additional pumping assembly 110 as described in other embodiments. The two pumping assemblies 110 can be rotationally connected via the torque member 122 or can rotate independently. In other embodiments, the distal end of the catheter body 104 can include other chopping or tissue destruction elements, such as a screw, an auger, or a pulverizer. Other types of pumps in the handle assembly 106 can be envisioned, such as a piston pump, a diaphragm pump, a peristaltic pump, a centrifugal pump, a screw pump, a rotary gear pump, or any other suitable pumping mechanism.
[0185] The following is a discussion of various alternative or supplementary features that may be included in embodiments of the present disclosure. Unless specifically noted, it should be assumed that any alternative discussed in the following sections may be combined or applied to any embodiment included in the present disclosure or otherwise covered by its scope.
[0186] In some embodiments, the rotor 116 may have various coatings or textures along its rotor spiral section 214. The coating may be a lubricating coating, such as a hydrophilic or hydrophobic coating or a metal plating. Alternatively, the outer surface may be textured or coated to provide additional friction to pull the clot into the stator 114. In other embodiments, the rotor spiral section 214 may include an elastomeric coating on its outer surface, making it a sealing member, and the stator 114 may therefore be composed of a harder material (such as a thermoplastic or metal) that is less compressible. In such an embodiment, the seal is mainly achieved by compressing a portion of the rotor 116 rather than the stator 114. In other embodiments, neither the rotor 116 nor the stator 114 is an elastic material, and no seal is achieved during operation of the device. For example, there may be a spacing gap between the rotor 116 and the stator 114, which creates an unsealed cavity, but when the rotor 116 spins, the pumping assembly 110 still behaves like a pump, but includes some slippage due to the spacing gap. Slippage can beneficially prevent effective evacuation of low viscosity fluids such as blood, but still enable pumping of more viscous materials such as clots. This can beneficially reduce blood loss during clot extraction. Such spacing gaps are sometimes implemented in progressive cavity pumps to allow for manufacturing tolerances of components.
[0187] In some embodiments, the stator 114 has a rounded or tapered distal edge, rather than a sharp distal edge as shown in many of the figures. The rounded distal edge can prevent vessel damage by providing a smoother surface to contact the vessel wall.
[0188] In some embodiments, the pumping assembly 110 does not pump fluid. For example, the stator spiral portion 210 or the rotor spiral section 214 can be composed of only a part (such as one-half) of the full pitch cavity. In such an embodiment, the fully closed cavity 224 is not realized between the stator spiral lumen 210 and the rotor spiral section 214, because there will be a section where the lumen of the catheter body 104 is fluidically connected to the rotor 116 of the fluid at the distal end of the device 102. A separate suction source can be applied to the device 102, for example, through the outlet tube 132, to suck fluid and material into the catheter body 104. The rotor 116 can then rotate to help take in materials that may otherwise have been blocked. In this way, the tissue engaging portion 108 including the self-rotating rotor 116 is combined with a separate suction source that can include a pump to remove fluid and material. The suction source can be a pump in the handle assembly 106, such as a piston pump, a peristaltic pump or any other type of pump. The rotor 116 assists the suction power by disrupting the clot and pushing fragments of the clot into the catheter body 104. In some embodiments, the device 102 may not include a stator 114, and the rotor 116 may spin within the catheter body 104 instead.
[0189] In some embodiments, the device 102 may include more than one pumping assembly 110. For example, the catheter body 104 may have one or more pumping assemblies 110 along its length, which further help remove material from the patient's body or prevent the catheter body 104 from becoming blocked. Multiple pumping assemblies 110 can be connected rotationally by one or more torque members 122 like a daisy chain. In other embodiments, the pumping assemblies 110 can rotate at different speeds and timings. The pumping assemblies 110 can all have the same pumping parameters such as pitch and diameter, or can be unique. In some embodiments, the entire length of the catheter body 104 can have a single or multiple pumping assemblies 110. In addition, multiple inlet holes or outlet holes can be present on the catheter body 104. Some pumping assemblies 110 can be positioned inside the patient's body, while other pumping assemblies can be positioned outside the patient's body during their intended use.
[0190] In some embodiments, the distal bend 206 can be configured in various ways. In some embodiments, the distal bend can be a rigid angle, while in other configurations, the distal bend can be flexible and deformable by tissue structure or by the user before operation. In other embodiments, the distal bend 206 can be steerable. For example, the handle assembly 106 can include an interface that allows the user to actively adjust the angle of the distal bend 206. This can be achieved by a control line or any other suitable mechanism. In some embodiments, the rotation of the catheter hub 124 and the catheter body 104 can be automatically completed by the handle assembly 106. For example, a separate motor can drive the rotation of the catheter hub 124 at a desired speed or relative to the main motor 416 that drives the pump assembly. In other embodiments, the rotation of the catheter hub 124 can be driven by the motor 416, possibly driven by a gear reduction device that spins the end of the device once for a given number of revolutions of the rotor 116. The user may be able to provide input and control of the motorized rotation of the catheter hub 124. Spinning of the catheter hub 124 may help ensure that the distal bend 206 guides the tissue engaging portion 108 around the lumen of the vessel 604 .
[0191] In some embodiments, the controller 136 can apply different rotation profiles to the drive system 130 and the motor 416. For example, in one embodiment of the rotation profile, the motor speed is proportional to the throttle 418 user input. As the user further depresses the throttle 418, the motor 416 spins faster. In other embodiments of the rotation profile, the throttle 418 can switch between certain discrete motor 416 speeds. For example, a low motor 416 speed can be used to ingest low flow blood and acute soft clots 602. Then, as described elsewhere, feedback can be provided to the user indicating that a thicker clot 602 is encountered, and therefore the user can further depress the throttle 418 to achieve a higher discrete speed optimized for clot 602 ingestion. In other embodiments of the rotation profile, the controller 136 can include additional profiles, such as pulsed rotation, in which the pump rotates at a high speed for discrete amounts of time with pauses in between. For example, the controller 136 can be configured to spin the motor 416 for a first discrete number of revolutions at a first speed, and then spin for a second discrete number of revolutions at a second discrete speed, or alternatively can be configured to stop rotating for a discrete amount of time. The controller 136 can repeatedly execute this mode. In other embodiments of the rotation profile, the controller 136 motor profile can include a cycle of high-speed pumping with a short rotation pulse train in opposite directions that discharges a small amount of fluid. These profiles can improve clot destruction and ingestion when mixing clots and blood. In some embodiments, the pulse profile can generate a pulsed vacuum at the distal end of the catheter, which can help ingest clots. In some embodiments of the rotation profile, the user can provide input to the controller 416 and adjust the rotation profile. Many motor rotation profiles can be envisioned.
[0192] In some embodiments, the handle assembly 106 can be divided into a disposable component and a reusable component. For example, the catheter body 104 and the catheter hub 124 and all distal elements and the collection assembly 112 can be disposable, while the majority of the handle assembly 106 can be a durable component. In this way, the user can connect the disposable and reusable parts, perform the operation, and then dispose of the catheter assembly while cleaning and reusing the handle assembly 106. Many other configurations are contemplated.
[0193] In some embodiments, the controller 136 can adjust the speed of the motor 416 according to the torque required to rotate the rotor 116. For example, when the pump assembly 110 is taking in fluid, it will likely require a lower torque to rotate than when the tissue engaging portion 108 is taking in a viscous material such as a clot. One estimate of the torque applied is the current that the motor 416 uses to rotate at a given speed. The controller 136 can define different profiles based on the motor 416 current, wherein the profile provides a relationship between torque and rotational speed. Therefore, when the torque applied by the motor 416 changes, the controller 136 can adjust the rotational speed of the rotor 116 based on the profile.
[0194] For example, if the motor 416 only takes blood, it can rotate at a slower speed, and thus reduce blood loss. In some embodiments, the baseline torque can be set individually for each device by rotating the motor in air, water, saline or blood. For example, at the time of manufacture, the baseline torque can be stored in the controller 136, or alternatively can be established during the initialization or pre-injection step performed by the user. Therefore, the baseline can be used to determine whether the pump assembly 110 is taking clots or engaging with other vascular structures. The motor 416 speed can be adjusted accordingly. In other embodiments, the baseline can be dynamically established by the controller based on sampling of previously recorded measurements (such as motor current). Other methods of measuring the torque required to rotate the rotor can be envisioned, such as motor voltage, torque meter or any other suitable feedback. Once the tissue engaging portion 108 begins to engage with the clot and take the clot, the motor 416 current increases, and the controller 136 can increase the speed of the motor 416 to more efficiently take the clot. For example, the baseline torque that can be established before starting the procedure can be from about 0.1 mN·m and including about 0.1 mN·m to about 200 mN·m and including about 200 mN·m or about 10 mN·m. Then, the controller 136 can determine that the clot is engaged and change the speed of the motor 416 if the torque increases from about 5% and including about 5% to about 80% and including about 80% or about 20%. Many profiles in various states can be envisioned. In another embodiment, the same method can be used to determine whether a blood vessel or other vulnerable structure is engaged with the tissue engaging portion 108, and the controller 136 can completely stop the drive system 130 or even reverse it. Feedback can be provided to the user in many ways. For example, an auditory tone can be adjusted in volume or frequency and alert the user whether the pump assembly 110 is taking blood and the tissue engaging portion 108 is encountering a clot. Many different user interfaces can be used, such as light, sound, or vibration.
[0195] In some embodiments, the device 102 can be connected to a user interface, such as a smart phone, tablet, computer, or controller box. Bluetooth, Wi-Fi, Zigbee, a wired connection, or any other suitable method can be used to connect to the device 102. The user can adjust the controller 136 through the user interface and thereby change the way the device 102 responds to different inputs such as the throttle 418. In some embodiments, the device 102 can be controlled by other user inputs. For example, a foot pedal can be used as the throttle 418 instead of a trigger.
[0196] In some embodiments, the device 102 can record data from a given procedure and store the data in the controller 136 or transmit the data to a separate recording device via a wireless or wired connection. The data may include information such as the volume of blood removed, a torque profile indicating clot engagement, length of use, or any other information generated during the procedure. The user can review the data or store it for future reference.
[0197] In some embodiments, the filter assembly 712 can be located within the handle assembly 106. In such an embodiment, blood discharged from the manifold 128 can be fed directly into the filter assembly 712 within the handle assembly 106, which separates the clot material from the blood. The return tube 716 can feed the filtered blood through the catheter body 104 and out of the side hole. In this way, the device 102 can not require external tubes, which can simplify setup and operation. The filtered clot can be contained in the collection assembly 112 within the handle assembly 106. In some embodiments, the catheter body 104 can include a plurality of fenestrations proximal to the pumping assembly 110, which allows blood to return to the patient, but filters the clot and keeps it within the catheter body 104. In this embodiment, the catheter body 104 itself or a component within the catheter body 104 can act as the filter assembly 712.
[0198] In some embodiments, the pump assembly can be used with FIG. 3A to FIG. 3F 108 to dispense material out of the pumping assembly 110. For example, if the pumping assembly 110 or the tissue engaging portion 108 becomes blocked, the controller 136 can rotate the drive system 130 counterclockwise and thereby dispense material out of the pumping assembly 110. This can beneficially unclog the pumping assembly 110 and allow the user to resume removal of material. In some embodiments, this can be done at fixed intervals during the run time or at the end of the pumping operation to automatically unclog the device without user input. In other embodiments, the reversal of the pumping assembly 110 can be used to release a blood vessel or valve or other tissue that is not intended to be engaged by the tissue engaging portion 108.
[0199] In some embodiments, the stiffness of the stator 114 material can be selected based on the material to be removed. For example, when removing an acute fresh clot, a user can select a device 102 having a stator 114 constructed of a more elastic material, such as silicone with a Shore 35A. When removing a thicker chronic clot, a user can select a device 102 having a stator 114 constructed of nylon or a similarly rigid plastic.
[0200] In some embodiments, the device 102 can be primed with a fluid prior to use. For example, a user can place the tip of the device 102 into a container of saline and activate the device 102, thereby pumping saline into the catheter body 104. Alternatively, a user can prime the pumping assembly 110 with a grease or lubricant prior to clinical use.
[0201] Experimental Results
[0202] according to Figure 1A The embodiment and design shown in the prototype device are constructed. The stator 114 is made of elastic Shore 80A material, and other materials are 3D printed in hard plastic. The catheter body 104 is a HDPE extrusion, and a 24-volt brushless DC motor 416 is used in the drive system 130. Tests were conducted to evaluate the ability to extract clots from simulated blood vessels. An artificial clot simulation weighing 6.3 gm is placed between two light-transmitting plates, which include cylindrical cutouts. The model is pressurized with saline from a gravity-fed reservoir at a height of about 12 cm. The device 102 is inserted through the hemostatic valve and into the model. The pumping assembly 110 is activated by the throttle valve 418 and the motor 416. When the rotor 116 rotates, the fluid is pumped through the device and leaves the outlet tube. Then the tissue engaging portion 108 is advanced toward the clot simulation. The tissue engaging portion 108 and the pumping assembly 110 efficiently remove the clot simulation within 19 seconds, and the measured volume of the discharged fluid is only 52 mL. Experimental results demonstrate that this embodiment of the device 102 works as expected.
[0203] Many descriptions have been given of thrombectomy procedures in which clots and thrombi are removed, but this is not intended to limit the scope or use of the device 102 to such procedures. For the elimination of doubt, the terms clot and thrombus can be considered interchangeable with any material being removed. The device 102 can have a variety of shapes and sizes and is used as a platform for any type of thrombectomy, embolectomy, or foreign body, stone, or tissue removal in any part of the body or blood vessels. This can include, but is not limited to, cerebral thrombosis leading to ischemic stroke, acute and chronic deep vein thrombosis, pulmonary embolism, dural sinus thrombosis, controlled aspiration of tissue and / or fluid during surgery of the ventricular system or brain, removal of liquid embolic agents, clotted hemodialysis grafts, peripheral arterial thromboembolism (including mesenteric and peripheral vascular trees), peripheral arterial occlusions, critical limb ischemia (CLI), chronic total occlusion (CTO), and stone removal. The device 102 can also be used for debulking procedures used to remove tumors and other cancerous materials.
[0204] Many other suitable applications may use such a device 102 to remove tissue, foreign matter, stones, or other objects within a tubular containment space or even a non-tubular or non-containment space. In some embodiments, the device 102 may be used to remove tissue during small-port laparoscopic procedures, including biopsies or removal of malignant tissue.
[0205] The names and labels applied to the various components and parts should not be construed as limiting the scope of the apparatus and method of the invention.
[0206] Although various methods and apparatus embodiments are described in detail herein with reference to certain forms, it should be understood that other forms, forms, methods of use and combinations thereof are also possible. Therefore, the spirit and scope of the appended claims should not be limited to the description of the embodiments contained herein.
[0207] Illustrative Aspects of the Disclosure
[0208] Illustrative examples of the present disclosure include, but are not limited to, the following:
[0209] Aspect 1: An apparatus comprising: a catheter including a lumen extending through the catheter; and a progressive cavity pump at a distal portion of the catheter, wherein the progressive cavity pump is in communication with each of the lumen and an external environment surrounding the distal portion of the catheter, and wherein the progressive cavity pump is operable to transfer material from the external environment into the lumen of the catheter.
[0210] Aspect 2: The device according to aspect 1, further comprising a container in fluid communication with the proximal end of the lumen, wherein the container is configured to provide or receive material transferred through the lumen.
[0211] Aspect 3: The apparatus of aspect 1, wherein the progressive cavity pump is coupled to and extends from the distal end of the catheter.
[0212] Aspect 4: The apparatus of aspect 1, wherein the progressive cavity pump is at least partially disposed within the lumen at the distal end of the catheter.
[0213] Aspect 5: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator formed at least in part from an elastomeric material.
[0214] Aspect 6: The apparatus of aspect 1, wherein the progressive cavity pump comprises each of a stator defining a helical stator lumen and a helical rotor extending through the helical stator lumen, and wherein a pitch of the helical stator lumen is approximately twice a pitch of the helical rotor.
[0215] Aspect 7: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator and a rotor arranged to form a cavity therebetween, and wherein the cavity is fluid-sealed due to compression between the stator and the rotor.
[0216] Aspect 8: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator and a rotor arranged to form a cavity therebetween, and wherein the cavity is unsealed due to a spacing gap between the stator and the rotor.
[0217] Aspect 9: The apparatus of aspect 1, wherein the progressive cavity pump comprises a rotor, the apparatus further comprising a torque member extending through the lumen and coupled to the rotor, the torque member operable to transmit torque applied to a proximal end of the torque member to the rotor.
[0218] Aspect 10: The apparatus of aspect 1, wherein the progressive cavity pump comprises a rotor, the apparatus further comprising a motor coupled to the rotor and operable to drive the rotor.
[0219] Aspect 11: The apparatus of aspect 1, wherein the distal end of the catheter comprises an angled tip.
[0220] Aspect 12: The device of aspect 1, wherein the distal portion has an outer diameter of from about 6 French and including about 6 French to about 20 French and including.
[0221] Aspect 13: The device of aspect 1, wherein the progressive cavity pump forms a seal between the lumen and the external environment.
[0222] Aspect 14: The apparatus of aspect 1, further comprising a handle assembly coupled to the proximal end of the catheter, wherein the handle assembly comprises a drive system for controlling the progressive cavity pump.
[0223] Aspect 15: The device according to Aspect 1 also includes a distal pumping assembly, which is connected to the distal end of the catheter and includes a progressive cavity pump, wherein the distal pumping assembly includes a sleeve, which is connected to the stator of the progressive cavity pump and rotationally fixes the stator of the progressive cavity pump relative to the sleeve.
[0224] Aspect 16: The apparatus of aspect 1, further comprising a distal pumping assembly disposed within the distal end of the catheter and comprising a progressive cavity pump.
[0225] Aspect 17: The device according to Aspect 1 also includes a distal pumping assembly connected to the distal end of the catheter and including a progressive cavity pump, wherein the progressive cavity pump includes each of a stator and a rotor, the distal pumping assembly includes a positioning element disposed at the proximal end of the stator, and the positioning element is configured to maintain an axial relationship between the stator and the rotor during operation of the distal pumping assembly.
[0226] Aspect 18: The apparatus of aspect 1, wherein the progressive cavity pump comprises a rotor coupled to a drive system configured to rotate the rotor at a plurality of rotational speeds.
[0227] Aspect 19: The apparatus of aspect 18, wherein the drive system is configured to change between speeds in the plurality of rotational speeds in response to torque applied by the drive system.
[0228] Aspect 20: The apparatus of aspect 19, wherein the torque applied by the drive system is estimated based on the current drawn by the motor of the drive system.
[0229] Aspect 21: The apparatus of Aspect 19, wherein the drive system includes a profile defining one or more relationships between torque and rotational speed, and wherein the drive system is configured to change between speeds in the plurality of rotational speeds in response to torque based on the profile.
[0230] Aspect 22: The apparatus of aspect 1, further comprising a collection assembly in communication with the lumen of the catheter, the collection assembly being configured to receive material ingested by the progressive cavity pump, wherein the collection assembly comprises a filtration system.
[0231] Aspect 23: The apparatus of aspect 22, further comprising a return tube in communication with the collection assembly, the return tube being configured to receive material not retained by the filter.
[0232] Aspect 24: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator defining a stator lumen and a stator opening separate from the stator lumen, the apparatus further comprising a visualization assembly supported within the stator opening.
[0233] Aspect 25: The apparatus of aspect 24, wherein the visualization assembly includes a cable, and the stator defines a channel through which the cable extends.
[0234] Aspect 26: The apparatus of aspect 25, wherein the channel extends helically around the stator.
[0235] Aspect 27: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator defining a stator lumen and a channel separate from the stator lumen.
[0236] Aspect 28: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator defining a stator lumen and a channel separate from the stator lumen and extending along an outer surface of the stator.
[0237] Aspect 29: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator defining a stator lumen and a channel separate from the stator lumen and extending helically along an outer surface of the stator.
[0238] Aspect 30: The apparatus of aspect 1, wherein the progressive cavity pump comprises a stator defining a stator lumen and a plurality of channels separated from the stator lumen.
[0239] Aspect 31: The device of aspect 1, further comprising a port extending between the interior volume of the device and the external environment and positioned proximal to the progressive cavity pump.
[0240] Aspect 32: The device of aspect 31, wherein the port is sized to receive at least one of a guidewire and a microcatheter.
[0241] Aspect 33: A method comprising: positioning a material removal device within a physiological lumen or cavity of a patient, the material removal device comprising: a catheter comprising a catheter lumen extending through the catheter; and a progressive cavity pump at a distal portion of the catheter, wherein the progressive cavity pump is in communication with the catheter lumen and each of the patient's physiological lumen or cavity; actuating the progressive cavity pump to take up material from the physiological lumen or cavity into the catheter lumen.
[0242] Aspect 34: The method according to aspect 33, further comprising delivering the material through the catheter lumen to a container disposed outside the patient's body and in communication with the proximal end of the catheter lumen.
[0243] Aspect 35: The method of aspect 33, wherein the progressive cavity pump comprises a stator and a rotor arranged to form a cavity therebetween, wherein actuating the progressive cavity pump ingests material into the cavity.
[0244] Aspect 35: The method according to aspect 33, wherein the material removal device is an apparatus according to any one of aspects 1 to 32.
[0245] Aspect 36: A method according to Aspect 33, wherein the material removal equipment is an equipment according to Aspect 18, and the method further includes rotating the rotor at a first speed among the multiple rotational speeds; obtaining a torque applied to the rotor by the drive system while rotating the rotor at the first speed; and changing the rotational speed of the rotor to a second rotational speed among the multiple rotational speeds in response to the torque.
[0246] Aspect 36: A method according to Aspect 33, wherein the material removal equipment is an equipment according to Aspect 19, and the method further includes rotating the rotor at a first speed among the multiple rotational speeds; obtaining a torque applied to the rotor by the drive system while rotating the rotor at the first speed; and changing the rotational speed of the rotor to a second rotational speed among the multiple rotational speeds in response to the torque and according to the profile.
[0247] Aspect 37: The method of aspect 33, further comprising transferring the material to a collection assembly in communication with the catheter lumen and external to the patient.
[0248] Aspect 38: The method of aspect 37, further comprising filtering the ingested material using a filter assembly disposed within or in line with the collection assembly.
[0249] Aspect 39: The method according to aspect 37, further comprising returning at least a portion of the ingested material to the patient through a return tube in communication with the collection assembly.
[0250] Aspect 40: The method of aspect 33, wherein the progressive cavity pump comprises a stator defining a stator lumen and a channel separate from the stator lumen, the method further comprising at least one of infusing a substance or applying suction through the channel.
[0251] Aspect 41: The method of Aspect 33, wherein positioning the material removal device comprises positioning the material removal device within a second catheter disposed within a physiological lumen or cavity of the patient.
[0252] Aspect 42: The method of aspect 41, wherein the material is disposed within a lumen of the second catheter, and uptake of the material from the physiological lumen or cavity into the catheter lumen comprises uptake of the material from within the lumen of the second catheter.
[0253] Aspect 43: The method of aspect 33, wherein positioning the material removal device comprises translating the material removal device along the guidewire.
[0254] Aspect 44: The method of aspect 43, wherein the material removal device is the device of aspect 31, and the guidewire extends through the port during translation of the material removal device along the guidewire.
Claims
1. A device comprising: a catheter comprising a lumen extending through the catheter; and A progressive cavity pump at a distal portion of the catheter, wherein the progressive cavity pump is in communication with each of the lumen and an external environment surrounding the distal portion of the catheter, and wherein the progressive cavity pump is operable to transfer material from the external environment into the lumen of the catheter.
2. The apparatus of claim 1 further comprising a container in fluid communication with the proximal end of the lumen, wherein The container is configured to provide or receive material transferred through the lumen.
3. The device according to claim 1, wherein: The progressive cavity pump is coupled to and extends from a distal end of the catheter.
4. The device according to claim 1, wherein: The progressive cavity pump is disposed at least partially within the lumen at a distal end of the catheter.
5. The device according to claim 1, wherein: The progressive cavity pump includes a stator formed at least in part from an elastomeric material.
6. The device according to claim 1, wherein: The progressive cavity pump includes each of a stator defining a helical stator lumen and a helical rotor extending through the helical stator lumen, and wherein a pitch of the helical stator lumen is approximately twice a pitch of the helical rotor.
7. The device according to claim 1, wherein: The progressive cavity pump comprises a stator and a rotor arranged to form a cavity therebetween, and wherein the cavity is fluid sealed due to compression between the stator and the rotor.
8. The device according to claim 1, wherein: The progressive cavity pump comprises a stator and a rotor arranged to form a cavity therebetween, and wherein the cavity is unsealed due to a spacing gap between the stator and the rotor.
9. The device according to claim 1, wherein: The progressive cavity pump includes a rotor, the apparatus further comprising a torque member extending through the lumen and coupled to the rotor, the torque member operable to transmit a torque applied to a proximal end of the torque member to the rotor.
10. The device according to claim 1, wherein: The progressive cavity pump includes a rotor, the apparatus further including a motor coupled to the rotor and operable to drive the rotor.
11. The device according to claim 1, wherein: The distal end of the catheter includes an angled tip.
12. The device according to claim 1, wherein: The distal portion has an outer diameter of from about 6 French and including to about 20 French and including.
13. The apparatus according to claim 1, wherein: The progressive cavity pump forms a seal between the lumen and the external environment.
14. The apparatus of claim 1, further comprising a handle assembly coupled to the proximal end of the catheter, wherein The handle assembly includes a drive system for controlling the progressive cavity pump.
15. The apparatus of claim 1 further comprising a distal pumping assembly coupled to the distal end of the catheter and comprising the progressive cavity pump, wherein The distal pumping assembly includes a sleeve coupled to and rotationally fixing a stator of the progressive cavity pump relative to the sleeve.
16. The apparatus of claim 1 further comprising a distal pumping assembly disposed within the distal end of the catheter and comprising the progressive cavity pump.
17. The apparatus of claim 1 further comprising a distal pumping assembly coupled to the distal end of the catheter and comprising the progressive cavity pump, wherein The progressive cavity pump includes each of a stator and a rotor, the distal pumping assembly includes a locating element disposed at a proximal end of the stator, and the locating element is configured to maintain an axial relationship between the stator and the rotor during operation of the distal pumping assembly.
18. A method comprising: Positioning a material removal device within a physiological lumen or cavity of a patient, the material removal device comprising: a catheter comprising a catheter lumen extending through the catheter; and a progressive cavity pump at the distal portion of the catheter, wherein the progressive cavity pump is in communication with each of the catheter lumen and the physiological lumen or cavity of the patient; The progressive cavity pump is actuated to uptake material from the physiological lumen or cavity into the catheter lumen.
19. The method of claim 18, further comprising delivering the material through the catheter lumen to a container disposed outside the patient's body and in communication with the proximal end of the catheter lumen.
20. The method according to claim 18, wherein: The progressive cavity pump comprises a stator and a rotor arranged to form a cavity therebetween, wherein actuating the progressive cavity pump ingests the material into the cavity.
